Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID Reference, 4th edition, 372 pages

+ the daily Top 10


  Breast Cancer

  Free Subscription


Articles published in Breast J

Retrieve available abstracts of 430 articles:
HTML format



Single Articles


    September 2020
  1. VALENTE S, Al-Hilli Z, Liu Y, Greve N, et al
    Association of patient factors with time to treatment for breast cancer.
    Breast J. 2020 Sep 13. doi: 10.1111/tbj.14046.
    PubMed     Abstract available


  2. GIULIANI J, Bonetti A
    The cost-effectiveness of trastuzumab emtansine (T-DM1) in HER2-positive metastatic breast cancer is supported by clinical evidence.
    Breast J. 2020 Sep 13. doi: 10.1111/tbj.14024.
    PubMed    


  3. MOSTAFAEI S, Vahidi Manesh P, Sadri Nahand J, Nesaei A, et al
    The role of Epstein-Barr virus-expressed genes in breast cancer development.
    Breast J. 2020 Sep 11. doi: 10.1111/tbj.14021.
    PubMed    


  4. SITTENFELD SMC, Murray E, Guo B, Tendulkar R, et al
    Treatment of diffuse cutaneous metastases from breast cancer.
    Breast J. 2020 Sep 11. doi: 10.1111/tbj.14049.
    PubMed    


  5. ACEA-NEBRIL B, Garcia-Novoa A, Garcia-Jimenez L, Escribano-Posada C, et al
    Impact of the COVID-19 pandemic on a breast cancer surgery program. Observational case-control study in a COVID-free hospital.
    Breast J. 2020 Sep 7. doi: 10.1111/tbj.14037.
    PubMed    


  6. WHITE RE, Warren L, Nakhlis F, Rosenbluth J, et al
    Characteristics associated with inflammatory breast cancer (IBC): An epidemiologic study from a dedicated IBC program.
    Breast J. 2020 Sep 1. doi: 10.1111/tbj.14030.
    PubMed     Abstract available


    August 2020
  7. PATWARI A, Bhatlapenumarthi V
    Diffuse peritoneal carcinomatosis with ascites and disseminated bone marrow carcinomatosis as initial presentation of occult breast cancer.
    Breast J. 2020 Aug 31. doi: 10.1111/tbj.14032.
    PubMed    


  8. PASRICHA S, Menon V, Gupta G, Kamboj M, et al
    Impact of 2018 ASCO/CAP guidelines on HER-2 reporting categories of IHC and reflex FISH in breast cancer.
    Breast J. 2020 Aug 31. doi: 10.1111/tbj.14031.
    PubMed     Abstract available


  9. GHANI S, Sochat M, Luo J, Tao Y, et al
    Characteristics of male triple negative breast cancer: A population-based study.
    Breast J. 2020 Aug 27. doi: 10.1111/tbj.14023.
    PubMed     Abstract available


  10. YU J, Olsen MA, Margenthaler JA
    Indications for readmission following mastectomy for breast cancer: An assessment of patient and operative factors.
    Breast J. 2020 Aug 26. doi: 10.1111/tbj.14029.
    PubMed     Abstract available


  11. GUTKIN PM, Kapp DS, von Eyben R, Dirbas FM, et al
    Impact of mastectomy for breast cancer on spinal curvature: Considerations when treating patients with scoliosis.
    Breast J. 2020 Aug 25. doi: 10.1111/tbj.14018.
    PubMed     Abstract available


  12. GUVEN DC, Sahin TK, Aksoy S
    The use of CDK 4/6 inhibitors in the adjuvant treatment of breast cancer: Timing matters.
    Breast J. 2020 Aug 19. doi: 10.1111/tbj.14027.
    PubMed    


  13. ODIKPO LC, Chiejina EN
    Assessment of barriers to practice of exercise among women with breast cancer in Delta State, Nigeria.
    Breast J. 2020 Aug 17. doi: 10.1111/tbj.13989.
    PubMed    


  14. MASOOD S
    Breast cancer risk assessment and management.
    Breast J. 2020 Aug 11. doi: 10.1111/tbj.14013.
    PubMed    


  15. MACHIELS M, Weytjens R, Erven K, Westerhoff JM, et al
    Oncological outcome, postoperative complications, and mammographic changes after intraoperative radiotherapy with electrons (IOERT) as a boost in a large single-institution cohort of breast cancer patients.
    Breast J. 2020 Aug 11. doi: 10.1111/tbj.13986.
    PubMed     Abstract available


  16. CHAHUAN B, Soza-Ried C, Farina A, Calvo FA, et al
    Management plan for breast cancer during the COVID-19 pandemic. A single-institution alternative to treat early breast cancer patients in a short time.
    Breast J. 2020 Aug 6. doi: 10.1111/tbj.13943.
    PubMed    


  17. SELLA T, Dowton AA, Meyer ME, Ruddy KJ, et al
    The utility of magnetic resonance imaging in early-stage breast cancer survivors-An institutional experience and literature review.
    Breast J. 2020 Aug 4. doi: 10.1111/tbj.13997.
    PubMed     Abstract available


  18. WOOD ME, McKinnon W, Garber J
    Risk for breast cancer and management of unaffected individuals with non-BRCA hereditary breast cancer.
    Breast J. 2020 Aug 2. doi: 10.1111/tbj.13969.
    PubMed     Abstract available


  19. CEN C, Chun J, Schnabel F
    Management of women at increased risk for breast cancer secondary to high-risk proliferative lesions and family history of the disease.
    Breast J. 2020 Aug 2. doi: 10.1111/tbj.13964.
    PubMed     Abstract available


  20. OLADERU OT, Singh AK, Ma SJ
    Association of endocrine therapy with overall survival in women with hormone receptor-positive, HER2-negative, node-negative breast cancer of favorable histology.
    Breast J. 2020 Aug 1. doi: 10.1111/tbj.13995.
    PubMed     Abstract available


  21. MASOOD S
    The role of pathologists in recognition of morphologic and biologic features of genetically mutated breast cancer.
    Breast J. 2020;26:1583-1588.
    PubMed     Abstract available


  22. GERLACH K, Phalak K, Patel M, Leung JWT, et al
    COVID-19: Current and future crisis planning in breast imaging.
    Breast J. 2020;26:1615-1617.
    PubMed    


  23. TESTORI A, Alloisio M, Errico V, Perroni G, et al
    Extraordinary emergency measures set up by a Breast Unit to prevent COVID-19: Report of our experience.
    Breast J. 2020;26:1611-1612.
    PubMed    


  24. SORBO G, Gagliano S, La Tessa C, Ferrarini R, et al
    Breast unit Efficacy with the relocation of the surgical breast team during the COVID-19 pandemic.
    Breast J. 2020;26:1613-1614.
    PubMed    


    July 2020
  25. BOTTY VAN DEN BRUELE A, Gemignani ML
    Management of ipsilateral supernumerary nipple at time of breast cancer diagnosis.
    Breast J. 2020 Jul 30. doi: 10.1111/tbj.13973.
    PubMed     Abstract available


  26. ARAUJO DCM, Duarte GM, Jales RM, Shinzato JY, et al
    Sentinel lymph node biopsy vs no axillary surgery in early breast cancer clinically and ultrasonographically node negative: A prospective randomized controlled trial-VENUS trial.
    Breast J. 2020 Jul 30. doi: 10.1111/tbj.13994.
    PubMed    


  27. AL AMERI M, Hachim IY, Al Hashmi FY, AlHarmoodi F, et al
    In vitro fertilization and its correlation with different breast cancer characteristics: single-center experience in Al Ain, United Arab Emirates.
    Breast J. 2020 Jul 28. doi: 10.1111/tbj.13993.
    PubMed    


  28. DE LA CRUZ-KU GA, Chambergo-Michilot D, Valcarcel B, Rebaza P, et al
    Lymph node ratio as best prognostic factor in triple-negative breast cancer patients with residual disease after neoadjuvant chemotherapy.
    Breast J. 2020 Jul 25. doi: 10.1111/tbj.13988.
    PubMed     Abstract available


  29. GUARINO S, Stocchi L, Massaioli C
    Ribociclib therapy in peritoneal carcinomatosis secondary to HER2-negative metastatic breast cancer: A clinical case with a positive outcome.
    Breast J. 2020 Jul 25. doi: 10.1111/tbj.13940.
    PubMed     Abstract available


  30. DAMODARAN S, Sember QC, Arun BK
    Clinical implications of breast cancer tumor genomic testing.
    Breast J. 2020 Jul 22. doi: 10.1111/tbj.13966.
    PubMed     Abstract available


  31. SHAH PD, Domchek SM
    The contemporary landscape of genetic testing and breast cancer: Emerging issues.
    Breast J. 2020 Jul 20. doi: 10.1111/tbj.13968.
    PubMed     Abstract available


  32. CUFFOLO G, Gahir-Atwal HK, Smith B
    One-step nucleic acid amplification CK19 copy number for sentinel node biopsy in breast cancer: Identification of new cutoffs to predict nonsentinel axillary node involvement.
    Breast J. 2020 Jul 17. doi: 10.1111/tbj.13977.
    PubMed     Abstract available


  33. MAGNO S, Linardos M, Carnevale S, Dilucca M, et al
    The impact of the COVID-19 pandemic on breast cancer patients awaiting surgery: Observational survey in an Italian University hospital.
    Breast J. 2020 Jul 17. doi: 10.1111/tbj.13889.
    PubMed    


  34. SCIARAFFA T, Guido B, Khan SA, Kulkarni S, et al
    Breast cancer risk assessment and management programs: A practical guide.
    Breast J. 2020 Jul 14. doi: 10.1111/tbj.13967.
    PubMed     Abstract available


  35. MIR A, Mohebbi N, Omranipour R, Sedaghat M, et al
    Study of pregabalin effect on postsurgical pain in breast cancer patients: A double-blind randomized clinical trial using placebo.
    Breast J. 2020 Jul 13. doi: 10.1111/tbj.13979.
    PubMed    


  36. SHARIFI A, Seiler S, Hwang H, Dogan BE, et al
    Neoplastic seeding of breast cancer along the core biopsy tract.
    Breast J. 2020 Jul 13. doi: 10.1111/tbj.13974.
    PubMed    


  37. MIYASHITA H, Satoi S, Cruz C, Malamud SC, et al
    Neo-adjuvant therapy for triple-negative breast cancer: Insights from a network meta-analysis.
    Breast J. 2020 Jul 13. doi: 10.1111/tbj.13978.
    PubMed     Abstract available


  38. POREMBKA JH, Ma J, Le-Petross HT
    Breast density, MR imaging biomarkers, and breast cancer risk.
    Breast J. 2020 Jul 11. doi: 10.1111/tbj.13965.
    PubMed     Abstract available


  39. COLLINS JM, Isaacs C
    Management of breast cancer risk in BRCA1/2 mutation carriers who are unaffected with cancer.
    Breast J. 2020 Jul 11. doi: 10.1111/tbj.13970.
    PubMed     Abstract available


  40. LERTBUTSAYANUKUL C, Pitak M, Ajchariyasongkram N, Rakkiet N, et al
    Long-term patient-rated cosmetic and satisfactory outcomes of early breast cancer treated with conventional versus hypofractionated breast irradiation with simultaneous integrated boost technique.
    Breast J. 2020 Jul 9. doi: 10.1111/tbj.13960.
    PubMed     Abstract available


  41. DOUCETTE K, Lai C, Pohlmann PR
    Rebound lymphocytosis in a patient with chronic lymphocytic leukemia after cessation of a CDK 4/6 inhibitor for concomitant breast cancer.
    Breast J. 2020 Jul 8. doi: 10.1111/tbj.13955.
    PubMed     Abstract available


  42. DESAI NV, Tung NM
    Medical Management of newly diagnosed breast cancer in a BRCA1/2 mutation carrier.
    Breast J. 2020 Jul 6. doi: 10.1111/tbj.13972.
    PubMed     Abstract available


  43. NGASERIN S, Chua HW, Chew MH, Tan BK, et al
    A tripartite approach can seek to optimize breast cancer management during a pandemic - Real-Time experience of a developing breast oncology unit in Singapore.
    Breast J. 2020 Jul 1. doi: 10.1111/tbj.13961.
    PubMed    


  44. SALGARELLO M, Adesi LB, Visconti G, Pagliara DM, et al
    Considerations for performing immediate breast reconstruction during the COVID-19 pandemic.
    Breast J. 2020;26:1485-1487.
    PubMed    


    June 2020
  45. CASELLA D, Fusario D, Cassetti D, Miccoli S, et al
    The patient's pathway for breast cancer in the COVID-19 era: An Italian single-center experience.
    Breast J. 2020 Jun 28. doi: 10.1111/tbj.13958.
    PubMed     Abstract available


  46. KIM E, Park B, Lee W, Min J, et al
    Metastatic breast cancer presented as great toenail pyogenic granuloma.
    Breast J. 2020 Jun 24. doi: 10.1111/tbj.13903.
    PubMed    


  47. PURI A, Reddy TP, Patel TA, Chang JC, et al
    Metastatic triple-negative breast cancer: Established and emerging treatments.
    Breast J. 2020 Jun 23. doi: 10.1111/tbj.13946.
    PubMed     Abstract available


  48. YOUSEFI KASHI AS
    Overall survival and related prognostic factors for familial breast cancer patients: A single institution study in Iran.
    Breast J. 2020 Jun 21. doi: 10.1111/tbj.13942.
    PubMed    


  49. SINDONI A, Fama F, Vinciguerra P, Gioffre-Florio M, et al
    Orbital metastasis in a male patient after seven years from breast cancer diagnosis.
    Breast J. 2020 Jun 15. doi: 10.1111/tbj.13937.
    PubMed    


  50. VAN ZEELAND M, Westhoff P, Wauters C, Bult P, et al
    Omission of axillary lymph node dissection after neoadjuvant chemotherapy for clinically node-positive breast cancer: How can we select patients?
    Breast J. 2020 Jun 10. doi: 10.1111/tbj.13930.
    PubMed    


  51. BROADBENT R, Ralston S, Lauder J, Howell S, et al
    Outcome of CT staging prior to neo-adjuvant chemotherapy in patients with early breast cancer.
    Breast J. 2020 Jun 10. doi: 10.1111/tbj.13931.
    PubMed    


  52. BAYRAKTAR S, Zhou JZ, Bassett R, Gutierrez Barrera AM, et al
    Clinical outcome and toxicity from taxanes in breast cancer patients with BRCA1 and BRCA2 pathogenic germline mutations.
    Breast J. 2020 Jun 4. doi: 10.1111/tbj.13922.
    PubMed     Abstract available


  53. PARISE CA, Caggiano V
    The influence of comorbidity on treatment and survival of triple-negative breast cancer.
    Breast J. 2020 Jun 2. doi: 10.1111/tbj.13924.
    PubMed     Abstract available


    May 2020
  54. ISMAILI N, El Majjaoui S
    Management of breast cancer during COVID-19 pandemic in Morocco.
    Breast J. 2020 May 30. doi: 10.1111/tbj.13925.
    PubMed    


  55. CORSI F, Caruso A, Albasini S, Bossi D, et al
    Management of breast cancer in an EUSOMA-accredited Breast Unit in Lombardy, Italy, during the COVID-19 pandemic.
    Breast J. 2020 May 30. doi: 10.1111/tbj.13926.
    PubMed    


  56. BOSSUYT V, Spring L
    Pathologic evaluation of response to neoadjuvant therapy drives treatment changes and improves long-term outcomes for breast cancer patients.
    Breast J. 2020 May 29. doi: 10.1111/tbj.13864.
    PubMed     Abstract available


  57. VILLASCO A, D'Alonzo M
    Extended endocrine therapy in premenopausal breast cancer patients: Where are we now?
    Breast J. 2020 May 29. doi: 10.1111/tbj.13895.
    PubMed     Abstract available


  58. TURASHVILI G, Wen HY
    Multigene testing in breast cancer: What have we learned from the 21-gene recurrence score assay?
    Breast J. 2020 May 26. doi: 10.1111/tbj.13859.
    PubMed     Abstract available


  59. CICCARESE M, Orlando L, Fedele P, Schiavone P, et al
    A multicenter phase II trial of nab-paclitaxel and capecitabine in HER-2 negative and triple- negative advanced breast cancer: Could be an old regimen a valid approach to a changing disease?
    Breast J. 2020 May 20. doi: 10.1111/tbj.13856.
    PubMed    


  60. TASDOVEN I, Karadeniz Cakmak G
    Breast cancer surgery under the shadow of COVID-19: Quest for optimal axillary management after neo-adjuvant chemotherapy.
    Breast J. 2020 May 20. doi: 10.1111/tbj.13892.
    PubMed    


  61. BAR-SELA G, Samih Y, Yerushalmi R, Leviov M, et al
    Ethnicity, recurrence score distribution, and clinical outcomes in ER + HER2-negative breast cancer patients in Israel: A registry analysis.
    Breast J. 2020 May 18. doi: 10.1111/tbj.13870.
    PubMed    


  62. BEN KRIDIS W, Khanfir A
    Delayed docetaxel extravasation in case of breast cancer.
    Breast J. 2020 May 18. doi: 10.1111/tbj.13882.
    PubMed    


  63. SAGARRA-ROMERO L
    Effects of breast cancer treatment on metabolic health.
    Breast J. 2020 May 16. doi: 10.1111/tbj.13852.
    PubMed    


  64. RAVINDHRAN B, Attigere Math H, Chalegere M, Raheem A, et al
    The efficacy of frozen gel packs on postoperative pain, and NSAID or narcotic use in patients undergoing surgery for axillary node-positive breast cancer.
    Breast J. 2020 May 10. doi: 10.1111/tbj.13871.
    PubMed    


  65. TONELLOTTO F, Bergmann A, Abrahao KS, de Aguiar SS, et al
    Lymphatic/vascular invasion has a negative impact on overall survival and disease-free survival in patients with breast cancer and positive axillary lymph nodes.
    Breast J. 2020 May 7. doi: 10.1111/tbj.13872.
    PubMed    


  66. SALDI S, Perrucci E, Fulcheri CPL, Mariucci C, et al
    Zinc-L-carnosine prevented dysphagia in breast cancer patients undergoing adjuvant radiotherapy: Results of a phase III randomized trial.
    Breast J. 2020 May 7. doi: 10.1111/tbj.13855.
    PubMed    


  67. PETROU P
    A systematic review of the economic evaluations of trastuzumab in metastatic breast cancer.
    Breast J. 2020 May 7. doi: 10.1111/tbj.13853.
    PubMed    


    April 2020
  68. LE NK, Gabrick KS, Chouairi F, Mets EJ, et al
    Impact of socioeconomic status on psychological functioning in survivorship following breast cancer and reconstruction.
    Breast J. 2020 Apr 26. doi: 10.1111/tbj.13849.
    PubMed     Abstract available


  69. FOLLETTE CJ, Humphrey C, Amin A, Balanoff C, et al
    Primary tumor resection in de novo stage IV breast cancer patients.
    Breast J. 2020 Apr 26. doi: 10.1111/tbj.13850.
    PubMed     Abstract available


  70. CONLEY CC, Garcia JD, Radford C, Reich RR, et al
    Acceptability and outcomes of multigene panel testing among young Black breast cancer survivors.
    Breast J. 2020 Apr 22. doi: 10.1111/tbj.13848.
    PubMed    


  71. THORPE CS, Niska JR, Anderson JD, Girardo ME, et al
    Acute toxicities after proton beam therapy following breast-conserving surgery for breast cancer: Multi-institutional prospective PCG registry analysis.
    Breast J. 2020 Apr 15. doi: 10.1111/tbj.13812.
    PubMed     Abstract available


  72. CAIRNS C, Greenwalt I, Fan KL, Willey SC, et al
    Contralateral axillary sentinel lymph node in breast cancer recurrence.
    Breast J. 2020 Apr 14. doi: 10.1111/tbj.13816.
    PubMed     Abstract available


  73. CHUDASAMA R, Hsu A, Constantinou M
    Orbital metastasis in inflammatory breast cancer.
    Breast J. 2020 Apr 14. doi: 10.1111/tbj.13839.
    PubMed    


  74. SILIPIGNI S, Ippolito E, Matteucci P, Santo B, et al
    Repeated courses of radiation treatment in an HER2-positive breast cancer patient with diffuse brain metastases: A case report.
    Breast J. 2020 Apr 11. doi: 10.1111/tbj.13844.
    PubMed     Abstract available


  75. STOFFAES L, Dumazet A, Deslee G, Mohammad Muttaqi Z, et al
    Sarcoidosis-like reaction during palbociclib treatment for metastatic breast cancer: A case report.
    Breast J. 2020 Apr 10. doi: 10.1111/tbj.13800.
    PubMed     Abstract available


  76. ECKHERT E, Laniakea B, Kurian AW
    A case of a trans-masculine patient receiving testosterone with a history of estrogen receptor-positive breast cancer.
    Breast J. 2020 Apr 7. doi: 10.1111/tbj.13829.
    PubMed    


  77. VRANIC S
    Letter to Editor: Apocrine carcinoma is the fact. Comment on the recent paper entitled "Invasive apocrine carcinoma of the breast: Myth or fact?" by Gurrado et al (Breast J. 2019;26(3):545-546.).
    Breast J. 2020;26:838.
    PubMed    


  78. GURRADO A, Serio G, Marzullo A
    Author's reply on letter to editor "Apocrine carcinoma is the fact" by Vranic S.
    Breast J. 2020;26:839-840.
    PubMed    


    March 2020
  79. TALLET A, Racadot S, Boher JM, Cohen M, et al
    The actual benefit of intraoperative radiation therapy using 50 kV x-rays in early breast cancer: A retrospective study of 676 patients.
    Breast J. 2020 Mar 31. doi: 10.1111/tbj.13827.
    PubMed     Abstract available


  80. UPADHYAY R, Pandey R, Nand Sharma D, Gupta S, et al
    Concurrent or sequential hormonal therapy in era of hypofractionation in early breast cancer: A single-institution prospective study.
    Breast J. 2020 Mar 29. doi: 10.1111/tbj.13825.
    PubMed    


  81. CARBONI F, Covello R, Carosi MA, Valle M, et al
    The diagnostic challenge of solitary ovarian mass after breast cancer.
    Breast J. 2020 Mar 24. doi: 10.1111/tbj.13819.
    PubMed    


  82. DOSTALEK L, Lednicky S, Saskova P, Steyerova P, et al
    Is it possible to abandon sentinel lymph node biopsy in breast cancer patients with negative axillary ultrasound in the post-Z0011 era? A retrospective analysis.
    Breast J. 2020 Mar 18. doi: 10.1111/tbj.13814.
    PubMed    


  83. LOMBARDI A, Vitale V, Nigri G, Olivieri C, et al
    Prognostic impact of the 8th edition of American Joint Committee on Cancer (AJCC) cancer staging system on clinically negative lymph nodes (cN0) breast cancer patients.
    Breast J. 2020 Mar 16. doi: 10.1111/tbj.13807.
    PubMed     Abstract available


  84. LOHANI KR, Kumar C, Kataria K, Srivastava A, et al
    Role of tranexamic acid in axillary lymph node dissection in breast cancer patients.
    Breast J. 2020 Mar 15. doi: 10.1111/tbj.13810.
    PubMed     Abstract available


  85. HOLLINGSWORTH AB, Pearce MR, Stough RG
    Breast cancer survival following MRI detection in a high-risk screening program.
    Breast J. 2020 Mar 12. doi: 10.1111/tbj.13813.
    PubMed     Abstract available


  86. VAN EGDOM LSE, Pusic A, Verhoef C, Hazelzet JA, et al
    Machine learning with PROs in breast cancer surgery; caution: Collecting PROs at baseline is crucial.
    Breast J. 2020 Mar 11. doi: 10.1111/tbj.13804.
    PubMed     Abstract available


  87. GUO LN, Gawelek KL, Russell-Goldman E, Nambudiri VE, et al
    Seeding from percutaneous liver biopsy: A case of iatrogenic cutaneous breast cancer.
    Breast J. 2020 Mar 5. doi: 10.1111/tbj.13794.
    PubMed    


  88. RODRIGUEZ PALLEIRO MC, Krygier Waltier G
    The impact of 21-Gene Recurrence Score test and classic clinical-pathologic factors in guiding adjuvant therapy for HER-2 negative, ER-positive, early-stage breast cancer: A retrospective study.
    Breast J. 2020 Mar 3. doi: 10.1111/tbj.13787.
    PubMed    


  89. KHALLAF E, Wessam R, Abdoon M
    Targeted axillary dissection of carbon-tattooed metastatic lymph nodes in combination with post-neo-adjuvant sentinel lymph node biopsy using 1% methylene blue in breast cancer patients.
    Breast J. 2020 Mar 2. doi: 10.1111/tbj.13736.
    PubMed    


  90. STRACH MC, Prasanna T, Carrigy MA, Bilton K, et al
    Impact of a novel breast cancer survivorship program on patient-centered outcomes: A single institutional study.
    Breast J. 2020 Mar 2. doi: 10.1111/tbj.13790.
    PubMed    


  91. CORACI D, Giovannini S, Loreti C, Fusco A, et al
    Management of neuropathic pain: A graph theory-based presentation of literature review.
    Breast J. 2020;26:581-582.
    PubMed    


    February 2020
  92. BEN KRIDIS W, Werda I, Mnejja W, Daoud J, et al
    Hormone resistance and breast cancer in young women: Correlated factors and survival impact.
    Breast J. 2020 Feb 26. doi: 10.1111/tbj.13795.
    PubMed    


  93. BOLAND MR, Heneghan HM, Ryan EJ, Ain Q, et al
    A systematic review and meta-analysis of the utility of lymphoscintigraphy in the management of clinically node-negative breast cancer.
    Breast J. 2020 Feb 24. doi: 10.1111/tbj.13791.
    PubMed    


  94. WEI CH, West R, Schmolze D, Apple SK, et al
    Clinical vs genomic risks in breast cancer in 2019: Breast pathologist's appellate review of the controversial results from TAILORx trial.
    Breast J. 2020 Feb 20. doi: 10.1111/tbj.13771.
    PubMed    


  95. PREAT F, Rondelli M, Delrue P, Anne-Sophie H, et al
    Contralateral axillary sentinel node: The hidden pathway in breast cancer.
    Breast J. 2020 Feb 18. doi: 10.1111/tbj.13777.
    PubMed    


  96. SILVA TB, Cardoso MAS, Ramim JE, Bergmann A, et al
    Pain-relievers prescription after bone metastasis detection in breast cancer patients: A Brazilian reference cancer hospital experience.
    Breast J. 2020 Feb 18. doi: 10.1111/tbj.13782.
    PubMed    


  97. WAKELEY ME, Bare CF, Pine R, Dube C, et al
    A social media survey of women who do not pursue reconstruction after mastectomy for breast cancer: Characterizing the "Going Flat" movement.
    Breast J. 2020 Feb 18. doi: 10.1111/tbj.13781.
    PubMed    


  98. CAO KI, Waechter L, Carton M, Kirova YM, et al
    Outcomes of exclusive radiation therapy for older women with breast cancer according to age and comorbidity status: An observational retrospective study.
    Breast J. 2020 Feb 14. doi: 10.1111/tbj.13764.
    PubMed     Abstract available


  99. LIMBACH KE, Leon E, Pommier RF, Pommier SJ, et al
    Comparison of breast cancer incidence, clinicopathologic features, and risk factor prevalence in women aged 20-29 at diagnosis to those aged 30-39.
    Breast J. 2020 Feb 14. doi: 10.1111/tbj.13783.
    PubMed    


  100. FERNANDEZ-GONZALEZ S, Falo C, Pla MJ, Verdaguer P, et al
    Predictive factors for omitting lymphadenectomy in patients with node-positive breast cancer treated with neo-adjuvant systemic therapy.
    Breast J. 2020 Feb 13. doi: 10.1111/tbj.13763.
    PubMed     Abstract available


  101. ZHAO Y, Sheng M, Zheng L, Xiong D, et al
    Application of circulating tumor DNA in breast cancer.
    Breast J. 2020 Feb 12. doi: 10.1111/tbj.13775.
    PubMed     Abstract available


  102. WANG L, Da H, Li X, Ran X, et al
    Comparison of CD4/6 inhibitors, PI3K inhibitors, and mTOR inhibitors for patients with advanced HR+/HER2- Breast cancer: A network meta-analysis of 19 RCTs.
    Breast J. 2020 Feb 9. doi: 10.1111/tbj.13780.
    PubMed    


  103. WANG L, Jorns JM
    Lymphocytic mastitis mimicking breast cancer in an elderly woman.
    Breast J. 2020 Feb 7. doi: 10.1111/tbj.13774.
    PubMed    


    January 2020
  104. CORREDOR J, Woodson AH, Gutierrez Barrera A, Arun B, et al
    Multigene panel testing results in patients with multiple breast cancer primaries.
    Breast J. 2020 Jan 30. doi: 10.1111/tbj.13762.
    PubMed     Abstract available


  105. BICCHIERAI G, Tonelli P, Piacenti A, De Benedetto D, et al
    Evaluation of contrast-enhanced digital mammography (CEDM) in the preoperative staging of breast cancer: Large-scale single-center experience.
    Breast J. 2020 Jan 30. doi: 10.1111/tbj.13766.
    PubMed     Abstract available


  106. NOWIKIEWICZ T, Glowacka-Mrotek I, Tarkowska M, Nowikiewicz M, et al
    Failure of sentinel lymph node mapping in breast cancer patients qualified for treatment sparing axillary lymph nodes-Clinical importance and management strategy-One-center analysis.
    Breast J. 2020 Jan 30. doi: 10.1111/tbj.13769.
    PubMed     Abstract available


  107. GUTKIN PM, Fero KE, Jacobson CE, Chen JJ, et al
    Health mindset is associated with anxiety and depression in patients undergoing treatment for breast cancer.
    Breast J. 2020 Jan 30. doi: 10.1111/tbj.13765.
    PubMed    


  108. RAFIROIU S, Vassil A, Valente SA
    Quinolone-induced radiation recall dermatitis in breast cancer patient.
    Breast J. 2020 Jan 30. doi: 10.1111/tbj.13756.
    PubMed    


  109. VALACHIS A, Garmo H, Fredriksson I, Sund M, et al
    Bleeding risk in breast cancer patients during concomitant administration of warfarin and tamoxifen: A population-based nested case-control study.
    Breast J. 2020 Jan 28. doi: 10.1111/tbj.13759.
    PubMed     Abstract available


  110. FRANCINI S, Rathat G, Manna F, Pages E, et al
    Occult lesion localization by indocyanine green fluorescence for nonpalpable breast cancer.
    Breast J. 2020 Jan 28. doi: 10.1111/tbj.13760.
    PubMed    


  111. LAYTON TB, Phillips B, Remoundos DD
    Papillary breast cancer: A retrospective single-centre clinical study.
    Breast J. 2020 Jan 24. doi: 10.1111/tbj.13746.
    PubMed     Abstract available


  112. GRANT SR, Krishnamurthy S, Le-Petross C, Valero V, et al
    An inflammatory imposter: Three cases of Mullerian carcinoma appearing as inflammatory breast cancer.
    Breast J. 2020 Jan 20. doi: 10.1111/tbj.13757.
    PubMed    


  113. FRANC BL, Thombley R, Luo Y, John Boscardin W, et al
    Using diagnosis codes in claims data to identify cohorts of breast cancer patients following initial treatment.
    Breast J. 2020 Jan 20. doi: 10.1111/tbj.13758.
    PubMed    


  114. SIQUEIRA RBA, Freitas-Junior R, Lopes PS, Lagares MS, et al
    Hydrotherapy following breast cancer surgery Phase II trial on hydrotherapy in women following breast cancer surgery.
    Breast J. 2020 Jan 20. doi: 10.1111/tbj.13744.
    PubMed    


  115. MORAN MS, Truong PT
    Hypofractionated radiation treatment for breast cancer: The time is now.
    Breast J. 2020 Jan 15. doi: 10.1111/tbj.13724.
    PubMed     Abstract available


  116. MACDONALD HR
    Pregnancy associated breast cancer.
    Breast J. 2020 Jan 14. doi: 10.1111/tbj.13714.
    PubMed     Abstract available


  117. DOE S, Petersen S, Swain M
    Utilization of genetic testing in breast cancer treatment after implementation of comprehensive multi-disciplinary care.
    Breast J. 2020 Jan 9. doi: 10.1111/tbj.13747.
    PubMed     Abstract available


  118. KUMAR M, Sebai ME, Appleford C, Dekhne N, et al
    Myxoma in the axilla of a patient with a history of inflammatory breast cancer.
    Breast J. 2020 Jan 2. doi: 10.1111/tbj.13741.
    PubMed    


  119. VOGEL VG
    Breast cancer risk reduction: Notable achievements and remaining challenges.
    Breast J. 2020;26:86-91.
    PubMed     Abstract available


    December 2019
  120. ORLANDI A, Aroldi F, Garutti M, Di Dio C, et al
    Poor efficacy of palbociclib in second-line treatment of metastatic lobular breast cancer in a case series: Use before or never more?
    Breast J. 2019 Dec 31. doi: 10.1111/tbj.13740.
    PubMed    


  121. PETRILLO A, Fusco R, Vallone P, Filice S, et al
    Digital breast tomosynthesis and contrast-enhanced dual-energy digital mammography alone and in combination compared to 2D digital synthetized mammography and MR imaging in breast cancer detection and classification.
    Breast J. 2019 Dec 30. doi: 10.1111/tbj.13739.
    PubMed     Abstract available


  122. MELNIK I, Yerushalmi R, Sobol Y, Magen A, et al
    Intraoperative radiation therapy for breast cancer-Immediate and 30-month oncological outcomes.
    Breast J. 2019 Dec 26. doi: 10.1111/tbj.13708.
    PubMed     Abstract available


  123. DJOHAN R, Knackstedt R
    Collaboration between breast and reconstructive surgery in optimizing outcomes for women with breast cancer.
    Breast J. 2019 Dec 26. doi: 10.1111/tbj.13723.
    PubMed     Abstract available


  124. BRUFSKY A, Mathew A
    Adjuvant bisphosphonate therapy in early-stage breast cancer-Treating the soil to kill the seed.
    Breast J. 2019 Dec 26. doi: 10.1111/tbj.13730.
    PubMed     Abstract available


  125. WONG RX, Kusumawidjaja G, Tan V
    Solitary contralateral axillary metastasis in breast cancer: Is it a true distant spread?
    Breast J. 2019 Dec 26. doi: 10.1111/tbj.13733.
    PubMed    


  126. HILAL T, Mi L, Ertz-Archambault NM, Almquist DR, et al
    Change in 21-gene Recurrence Score result after exposure to neo-adjuvant endocrine therapy in patients with operable breast cancer.
    Breast J. 2019 Dec 26. doi: 10.1111/tbj.13731.
    PubMed    


  127. GIULIANO AE
    The evolution of sentinel node biopsy for breast cancer: Personal experience.
    Breast J. 2019 Dec 26. doi: 10.1111/tbj.13729.
    PubMed     Abstract available


  128. AZIM HA, Ghosn M, Oualla K, Kassem L, et al
    Personalized treatment in metastatic triple-negative breast cancer: The outlook in 2020.
    Breast J. 2019 Dec 23. doi: 10.1111/tbj.13713.
    PubMed     Abstract available


  129. CARLSON GW
    The changing surgical treatment of breast cancer in the United States: The tipping point.
    Breast J. 2019 Dec 22. doi: 10.1111/tbj.13725.
    PubMed     Abstract available


  130. OHRI N, Haffty BG
    The evolution of adjuvant radiation therapy for early-stage and locally advanced breast cancer.
    Breast J. 2019 Dec 19. doi: 10.1111/tbj.13715.
    PubMed     Abstract available


  131. DIXON JM, Cartlidge CWJ
    Twenty-five years of change in the management of the axilla in breast cancer.
    Breast J. 2019 Dec 19. doi: 10.1111/tbj.13720.
    PubMed     Abstract available


  132. HUGHES KS, Zhou J, Bao Y, Singh P, et al
    Natural language processing to facilitate breast cancer research and management.
    Breast J. 2019 Dec 18. doi: 10.1111/tbj.13718.
    PubMed     Abstract available


  133. GIARRATANO T, Frezzini S, Zanocco M, Giorgi CA, et al
    Use of scalp cooling device to prevent alopecia for early breast cancer patients receiving chemotherapy: A prospective study.
    Breast J. 2019 Dec 14. doi: 10.1111/tbj.13711.
    PubMed     Abstract available


  134. WANG L, Gao S, Li D, Ran X, et al
    CDK4/6 inhibitors plus endocrine therapy improve overall survival in advanced HR+/HER2- breast cancer: A meta-analysis of randomized controlled trials.
    Breast J. 2019 Dec 11. doi: 10.1111/tbj.13703.
    PubMed    


  135. ONER G, Altintas S, Canturk Z, Tjalma W, et al
    Triple-negative breast cancer-Role of immunology: A systemic review.
    Breast J. 2019 Dec 4. doi: 10.1111/tbj.13696.
    PubMed     Abstract available


  136. MARTINEZ-CABRIALES SA, Sade S, Shear NH
    A progressive breast skin detachment in a breast cancer survivor.
    Breast J. 2019 Dec 2. doi: 10.1111/tbj.13706.
    PubMed    


  137. JOSTE M, Arsene-Henry A, Reyal F, Amessis M, et al
    Helical tomotherapy for patients presented with implant breast reconstruction in case of adjuvant breast cancer radiotherapy: A single center experience.
    Breast J. 2019 Dec 1. doi: 10.1111/tbj.13687.
    PubMed    


    November 2019
  138. CORTES J, Twelves C
    Impact of the number of prior chemotherapy regimens on outcomes for patients with metastatic breast cancer treated with eribulin: A post hoc pooled analysis.
    Breast J. 2019 Nov 29. doi: 10.1111/tbj.13686.
    PubMed     Abstract available


  139. BOUNOUS VE, Novara L, Scicchitano F, Villasco A, et al
    A retrospective analysis on 197 cases of breast cancer local recurrence: Biology, treatment, and prognosis.
    Breast J. 2019 Nov 25. doi: 10.1111/tbj.13698.
    PubMed    


  140. FUNDYTUS A, Saad N, Logie N, Roldan Urgoiti G, et al
    Breast cancer in transgender female-to-male individuals: A case report of androgen receptor-positive breast cancer.
    Breast J. 2019 Nov 20. doi: 10.1111/tbj.13655.
    PubMed     Abstract available


  141. SKOK K, Gradisnik L, Celesnik H, Potocnik U, et al
    Isolation and characterization of the first Slovenian human triple-negative breast cancer cell line.
    Breast J. 2019 Nov 20. doi: 10.1111/tbj.13695.
    PubMed    


  142. TAS F, Ozturker C
    Distichiasis in association with entropion in metastatic HER2-positive breast cancer treated by pertuzumab, trastuzumab, and docetaxel combination chemotherapy.
    Breast J. 2019 Nov 20. doi: 10.1111/tbj.13697.
    PubMed     Abstract available


  143. LANGABEER SE
    The JAK2 V617F mutation in breast cancer?
    Breast J. 2019 Nov 19. doi: 10.1111/tbj.13683.
    PubMed    


  144. NAEEM MA
    The JAK2 V617F mutation in breast cancer?
    Breast J. 2019 Nov 19. doi: 10.1111/tbj.13688.
    PubMed    


  145. FRANC BL, Thombley R, Luo Y, Boscardin WJ, et al
    Identifying tests related to breast cancer care in claims data.
    Breast J. 2019 Nov 18. doi: 10.1111/tbj.13691.
    PubMed     Abstract available


  146. SROUR MK, Gao B, Dadmanesh F, Carlson K, et al
    Gene expression comparison between primary triple-negative breast cancer and paired axillary and sentinel lymph node metastasis.
    Breast J. 2019 Nov 11. doi: 10.1111/tbj.13684.
    PubMed     Abstract available


  147. AZIM HA, Dawood S, El-Saghir N, Kassem L, et al
    Understanding the benefits and challenges of first-line cyclin-dependent kinases 4 and 6 inhibitors in advanced breast cancer among postmenopausal women.
    Breast J. 2019 Nov 10. doi: 10.1111/tbj.13637.
    PubMed     Abstract available


  148. MACDONALD HR
    Managing breast cancer risk in transgender men and women: Emerging safety data and a need for more research.
    Breast J. 2019;25:1063-1065.
    PubMed    


  149. VRANIC S
    Letter to editor/comment.
    Breast J. 2019;25:1330-1331.
    PubMed    


  150. TAKALA SJ, Heikkila P, Nevanlinna H, Blomqvist C, et al
    Reply-Letter to the editor.
    Breast J. 2019;25:1332.
    PubMed    


    October 2019
  151. ARSENE HENRY A, Amessis M, Kirova YM
    Helical Tomotherapy for patients with pectus excavatum treated for early-stage breast cancer.
    Breast J. 2019 Oct 24. doi: 10.1111/tbj.13671.
    PubMed    


  152. HAMZAH JL, Tan BKT, Tan V, Madhukumar P, et al
    A pilot study comparing Sentimag/Sienna versus standard modality for sentinel lymph node identification in patients with breast cancer.
    Breast J. 2019 Oct 14. doi: 10.1111/tbj.13660.
    PubMed    


  153. PALLESCHI M, Maltoni R, Sarti S, Melegari E, et al
    Immunotherapy: The end of the "dark age" for metastatic triple-negative breast cancer?
    Breast J. 2019 Oct 14. doi: 10.1111/tbj.13662.
    PubMed     Abstract available


  154. LI S, Alapati A, Riba L, Fleishman A, et al
    Delayed adjuvant hormonal therapy and its impact on mortality in women with breast cancer.
    Breast J. 2019 Oct 11. doi: 10.1111/tbj.13652.
    PubMed     Abstract available


  155. YANG K, Chun M
    Radiation recall dermatitis in response to adjuvant capecitabine immediately following postoperative radiotherapy in a patient with breast cancer.
    Breast J. 2019 Oct 3. doi: 10.1111/tbj.13627.
    PubMed     Abstract available


    September 2019
  156. TURKER S, Cilbir E, Yilmaz KB, Yetisgin E, et al
    Tumor-to-tumor metastasis: Breast cancer metastasis to lung cancer.
    Breast J. 2019 Sep 29. doi: 10.1111/tbj.13558.
    PubMed    


  157. YILMAZ KB, Saydam M, Tokgoz S, Akinci M, et al
    A novel monitorization technique for nerve protection during axillary surgery of the breast cancer patients.
    Breast J. 2019 Sep 28. doi: 10.1111/tbj.13644.
    PubMed    


  158. NAVARRO LC, Falcao-Junior PC, de Rezende ASM, Vieira RADC, et al
    Occult breast cancer associated with lymph node microcalcifications.
    Breast J. 2019 Sep 28. doi: 10.1111/tbj.13630.
    PubMed    


  159. TANG CYL, Lam WW, Tan PH, Xie W, et al
    Myoepithelial hyperplasia: A rare mimic of breast cancer on (18) F-FDG PET/CT.
    Breast J. 2019 Sep 28. doi: 10.1111/tbj.13643.
    PubMed    


  160. LAFORGA JB
    Lacrimal gland metastasis from invasive lobular carcinoma (ER(+) , PR(-) , Her-2(+) ) as the first manifestation of disseminated breast cancer.
    Breast J. 2019 Sep 28. doi: 10.1111/tbj.13640.
    PubMed    


  161. UPADHYAYA VS, Lim GH, Chan EYK, Fook-Chong SMC, et al
    Evaluating the preoperative breast cancer characteristics affecting the accuracy of axillary ultrasound staging.
    Breast J. 2019 Sep 27. doi: 10.1111/tbj.13635.
    PubMed     Abstract available


  162. OBI E, Tom MC, Manyam BV, Grobmyer SR, et al
    Outcomes with intraoperative radiation therapy for early-stage breast cancer.
    Breast J. 2019 Sep 27. doi: 10.1111/tbj.13574.
    PubMed     Abstract available


  163. SANCHEZ AM, Franceschini G, D'Archi S, De Lauretis F, et al
    Results obtained with level II oncoplastic surgery spanning 20 years of breast cancer treatment: Do we really need further demonstration of reliability?
    Breast J. 2019 Sep 27. doi: 10.1111/tbj.13490.
    PubMed     Abstract available


  164. LEHRBERG A, Bensenhaver J
    A rare presentation of bilateral, synchronous male breast cancer.
    Breast J. 2019 Sep 27. doi: 10.1111/tbj.13639.
    PubMed     Abstract available


  165. SAKIN A, Sakalar T, Sahin S, Yasar N, et al
    Factors affecting survival and treatment efficacy in breast cancer patients with bone marrow metastasis.
    Breast J. 2019 Sep 27. doi: 10.1111/tbj.13647.
    PubMed    


  166. MO W, Ding Y, Zheng Y, Zou D, et al
    Associations between folate metabolism enzyme polymorphisms and breast cancer: A meta-analysis.
    Breast J. 2019 Sep 23. doi: 10.1111/tbj.13527.
    PubMed     Abstract available


  167. SHAH C, Tendulkar RD
    Revisiting TARGIT-A and intraoperative radiation therapy for breast cancer.
    Breast J. 2019 Sep 23. doi: 10.1111/tbj.13629.
    PubMed    


  168. KANDAGATLA P, Rizk NN, Dokic D, Kochkodan J, et al
    Patient and provider factors associated with the noninitiation of tamoxifen for young women at high-risk for the development of breast cancer.
    Breast J. 2019 Sep 20. doi: 10.1111/tbj.13528.
    PubMed     Abstract available


  169. OVERGAAUW AJC, Speijers-van der Plas LM, Hendriks MP, Smorenburg CH, et al
    Outcome and feasibility of palliative chemotherapy in very elderly patients with metastatic breast cancer.
    Breast J. 2019 Sep 20. doi: 10.1111/tbj.13505.
    PubMed     Abstract available


  170. REYES SA, Williams AD, Arlow RL, De La Cruz LM, et al
    Changing practice patterns of adjuvant radiation among elderly women with early stage breast cancer in the United States from 2004 to 2014.
    Breast J. 2019 Sep 20. doi: 10.1111/tbj.13491.
    PubMed     Abstract available


  171. FRASSON AL, Filho AB, Lichtenfels M, de Souza ABA, et al
    Effect of intraoperative radiotherapy for early breast cancer on 10-year recurrence rates and overall survival.
    Breast J. 2019 Sep 20. doi: 10.1111/tbj.13502.
    PubMed     Abstract available


  172. WALKER RK, Berry DL
    Men with breast cancer experience stigma in the waiting room.
    Breast J. 2019 Sep 20. doi: 10.1111/tbj.13593.
    PubMed    


  173. PERERA N, Fernando N, Perera R, Jayasekara P, et al
    Metastatic breast cancer spread to peripancreatic lymph nodes causing biliary obstruction.
    Breast J. 2019 Sep 20. doi: 10.1111/tbj.13531.
    PubMed     Abstract available


  174. MAHTANI RL
    A role for fulvestrant monotherapy in the first-line treatment of ER+ metastatic breast cancer?
    Breast J. 2019 Sep 20. doi: 10.1111/tbj.13495.
    PubMed    


  175. STEININGER R, Bouton M, Marsh J
    Masson's tumor of the breast: Rare differential for new or recurrent breast cancer-Case report, pathology, and review of the literature.
    Breast J. 2019 Sep 20. doi: 10.1111/tbj.13608.
    PubMed     Abstract available


  176. RECHT A
    Breast cancer fractionation patterns: Why aren't they uniform, and should they be?
    Breast J. 2019 Sep 20. doi: 10.1111/tbj.13578.
    PubMed    


  177. ZHANG P, Du J, Fan C, Mo X, et al
    Utility of totally implantable venous access ports in patients with breast cancer.
    Breast J. 2019 Sep 20. doi: 10.1111/tbj.13595.
    PubMed    


  178. SKINNER KE, Olufade T, Walker MS, Schwartzberg LS, et al
    Real-world effectiveness of fulvestrant monotherapy as first endocrine treatment in patients with metastatic breast cancer.
    Breast J. 2019 Sep 17. doi: 10.1111/tbj.13492.
    PubMed     Abstract available


  179. BARCO NEBREDA I, Chabrera C, Garcia-Fernandez A, Gimenez N, et al
    Factors associated with the development of distant metastases in breast cancer patients-A regression model predicting organ relapse.
    Breast J. 2019 Sep 16. doi: 10.1111/tbj.13613.
    PubMed    


  180. MESSINGER J, Lee MV
    Paraneoplastic syndrome as the initial presentation for a mammographically occult breast cancer.
    Breast J. 2019 Sep 16. doi: 10.1111/tbj.13561.
    PubMed    


  181. SHAH C
    Bioimpedance spectroscopy in the detection of breast cancer-related lymphedema: An ounce of prevention.
    Breast J. 2019 Sep 13. doi: 10.1111/tbj.13618.
    PubMed    


  182. CHAN S, Sutradhar R, Yao Z, Chow E, et al
    Fractionation in adjuvant radiotherapy for invasive breast cancer and ductal carcinoma in situ in Ontario, Canada from 2009 to 2015.
    Breast J. 2019 Sep 12. doi: 10.1111/tbj.13515.
    PubMed     Abstract available


  183. MAZOUNI C, Conversano A, Laplace-Builhe C, Abbaci M, et al
    Reply-To Letter to the Editor; Prospective evaluation of the limitations of near-infrared imaging in detecting axillary sentinel lymph nodes in primary breast cancer.
    Breast J. 2019 Sep 12. doi: 10.1111/tbj.13626.
    PubMed    


  184. GRANA-LOPEZ L, Herranz M, Macineira FA, Villares A, et al
    Apparent diffusion coefficient: Potential biomarker for complete response after neo-adjuvant chemotherapy in breast cancer.
    Breast J. 2019 Sep 12. doi: 10.1111/tbj.13589.
    PubMed    


  185. NAEEM MA, Shah TH, Zafar N, Khan M, et al
    Detection of JAK2 gene mutation in Pakistani women with triple-negative breast cancer.
    Breast J. 2019 Sep 12. doi: 10.1111/tbj.13609.
    PubMed    


  186. LIVINGSTON-ROSANOFF D, Hanlon B, Marka N, Vande Walle K, et al
    Time to initiation of neo-adjuvant chemotherapy for breast cancer treatment does not influence patient survival: A study of US breast cancer patients.
    Breast J. 2019 Sep 12. doi: 10.1111/tbj.13625.
    PubMed     Abstract available


  187. BLACKHALL V, Bugelli M, Abbott N, Mullen R, et al
    The role of sentinel lymph node biopsy in planning adjuvant therapy for elderly women with low-risk breast cancer.
    Breast J. 2019 Sep 12. doi: 10.1111/tbj.13577.
    PubMed     Abstract available


  188. ABU SHAROUR L
    Psychometric evaluation of the Arabic version of the lymphedema life impact scale in breast cancer patients.
    Breast J. 2019 Sep 12. doi: 10.1111/tbj.13620.
    PubMed    


  189. LEE S, Jung Y, Bae Y
    Dermoglandular rotation flap with subaxillary advancement flap as an oncoplastic technique for breast cancer.
    Breast J. 2019 Sep 9. doi: 10.1111/tbj.13503.
    PubMed     Abstract available


  190. MCCORMICK B
    Changing the practice patterns of delivery of adjuvant radiation in the elderly with low-risk breast cancer: It's harder to do than you think!
    Breast J. 2019 Sep 9. doi: 10.1111/tbj.13496.
    PubMed    


  191. FRANCESCHINI G, Visconti G, Garganese G, Barone-Adesi L, et al
    Nipple-sparing mastectomy combined with endoscopic immediate reconstruction via axillary incision for breast cancer: A preliminary experience of an innovative technique.
    Breast J. 2019 Sep 9. doi: 10.1111/tbj.13529.
    PubMed     Abstract available


  192. AGARWAL S, Chang DW
    Breast reconstruction in the patient with stable, metastatic breast cancer.
    Breast J. 2019 Sep 9. doi: 10.1111/tbj.13596.
    PubMed    


  193. CATTIN F, Fogacci T, Frisoni G, Semprini G, et al
    Reply to: Prospective evaluation of the limitations of near-infrared imaging in detecting axillary sentinel lymph nodes in primary breast cancer.
    Breast J. 2019 Sep 8. doi: 10.1111/tbj.13607.
    PubMed    


  194. CHENG ML, See MH, Sinnadurai S, Islam T, et al
    Adherence rate and the factors contribute toward the surgical adherence of breast cancer in Malaysia.
    Breast J. 2019 Sep 8. doi: 10.1111/tbj.13617.
    PubMed    


  195. KONTOS M, Kostakis ID, Constantinidou A, Parkin A, et al
    Primary endocrine treatment for breast cancer in the elderly.
    Breast J. 2019 Sep 8. doi: 10.1111/tbj.13600.
    PubMed    


  196. FELIPE VC, Bitencourt AGV, Souza JA, de Azevedo MM, et al
    MRI features after radiofrequency ablation in breast cancer.
    Breast J. 2019 Sep 8. doi: 10.1111/tbj.13557.
    PubMed    


  197. CHO CH, Lee KL, Cho J, Kim D, et al
    The incidence and risk factors of frozen shoulder in patients with breast cancer surgery.
    Breast J. 2019 Sep 6. doi: 10.1111/tbj.13610.
    PubMed    


  198. THAINEUA V, Ansusinha T, Auamkul N, Taneepanichskul S, et al
    Impact of regular Breast Self-Examination on breast cancer size, stage, and mortality in Thailand.
    Breast J. 2019 Sep 6. doi: 10.1111/tbj.13611.
    PubMed    


  199. BARCO I, Garcia-Font M, Garcia-Fernandez A, Gimenez N, et al
    A regression model to predict axillary high tumor burden in sentinel node-positive breast cancer patients.
    Breast J. 2019 Sep 6. doi: 10.1111/tbj.13594.
    PubMed    


  200. FERSTENBERG M, Julian TB
    The ongoing evaluation and evolution of breast cancer surgical care.
    Breast J. 2019 Sep 6. doi: 10.1111/tbj.13526.
    PubMed     Abstract available


  201. KUMARI S, Malla RR
    Recent advances in metabolomics of triple negative breast cancer.
    Breast J. 2019 Sep 6. doi: 10.1111/tbj.13524.
    PubMed     Abstract available


  202. AZORIN SAMPER MDC, Hernandorena Gonzalez M, Ibanez Arias A, Diaz Sierra S, et al
    A case report of pseudoaneurysm after a core needle biopsy of breast cancer.
    Breast J. 2019 Sep 5. doi: 10.1111/tbj.13536.
    PubMed     Abstract available


  203. BOZKAYA Y, Ay B
    Toxic epidermal necrolysis associated with ribociclib in a patient with metastatic breast cancer.
    Breast J. 2019 Sep 4. doi: 10.1111/tbj.13570.
    PubMed    


  204. ELJUGA D, Milas I, Ozretic P, Stanec M, et al
    Prospective study on quality of life after oncoplastic and lumpectomy breast cancer procedures-Is there a difference?
    Breast J. 2019 Sep 4. doi: 10.1111/tbj.13585.
    PubMed    


  205. LIAW YY, Loong FS, Tan S, On SY, et al
    A retrospective study on breast cancer presentation, risk factors, and protective factors in patients with a positive family history of breast cancer.
    Breast J. 2019 Sep 4. doi: 10.1111/tbj.13520.
    PubMed     Abstract available


  206. ALTMAN AM, Nguyen DD, Johnson B, Marmor S, et al
    Intraoperative inking is superior to suture marking for specimen orientation in breast cancer.
    Breast J. 2019 Sep 3. doi: 10.1111/tbj.13508.
    PubMed     Abstract available


  207. MERRILL AL, Smith SM, Peters SB, Agnese DM, et al
    Eccrine carcinoma masquerading as metastatic breast cancer.
    Breast J. 2019 Sep 3. doi: 10.1111/tbj.13543.
    PubMed    


  208. KILLELEA BK, Evans SB, Mougalian SS, Gross CP, et al
    Association between perceived benefits and receipt of radiotherapy among older breast cancer patients.
    Breast J. 2019 Sep 3. doi: 10.1111/tbj.13518.
    PubMed     Abstract available


  209. DING DC, Sung FC, Chen W, Wang JH, et al
    Proton pump inhibitors reduce breast cancer risk in gastric ulcer patients: A population-based cohort study.
    Breast J. 2019 Sep 2. doi: 10.1111/tbj.13519.
    PubMed     Abstract available


  210. NIXON NA, Simmons C, Lemieux J, Verma S, et al
    Research priorities in metastatic breast cancer: A James Lind Alliance Priority Setting Partnership.
    Breast J. 2019 Sep 2. doi: 10.1111/tbj.13525.
    PubMed     Abstract available


    August 2019
  211. NAKHLIS F, Regan MM, Chun YS, Dominici LS, et al
    Patterns of breast reconstruction in patients diagnosed with inflammatory breast cancer: The Dana-Farber Cancer Institute's Inflammatory Breast Cancer Program experience.
    Breast J. 2019 Aug 25. doi: 10.1111/tbj.13509.
    PubMed     Abstract available


  212. GOOCH JC, Chun J, Kaplowitz E, Guth A, et al
    Pregnancy-associated breast cancer in a contemporary cohort of newly diagnosed women.
    Breast J. 2019 Aug 25. doi: 10.1111/tbj.13510.
    PubMed     Abstract available


  213. GELMON KA, Cristofanilli M, Rugo HS, DeMichele AM, et al
    Efficacy and safety of palbociclib plus endocrine therapy in North American women with hormone receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer.
    Breast J. 2019 Aug 25. doi: 10.1111/tbj.13516.
    PubMed     Abstract available


  214. ARCIERO C, Buhariwalla K, Liu Y, Torres MA, et al
    Time from Completion of Neo-adjuvant Chemotherapy to Surgery: Effects on Outcomes in Breast Cancer Patients.
    Breast J. 2019 Aug 25. doi: 10.1111/tbj.13482.
    PubMed     Abstract available


  215. CHRISTIAN N, Heelan Gladden A, Friedman C, Gleisner-Patton A, et al
    Increasing omission of radiation therapy and sentinel node biopsy in elderly patients with early stage, hormone-positive breast cancer.
    Breast J. 2019 Aug 25. doi: 10.1111/tbj.13483.
    PubMed     Abstract available


  216. HAMDY O, El-Badrawy A, Saleh GA, Metwally IH, et al
    Preoperative localization of sentinel lymph node in breast cancer patients by silver wire insertion or liquid charcoal injection guided by CT lymphography.
    Breast J. 2019 Aug 25. doi: 10.1111/tbj.13511.
    PubMed     Abstract available


  217. LA ROCCA E, Meneghini E, Dispinzieri M, Fiorentino A, et al
    Hypofractionated irradiation in 794 elderly breast cancer patients: An observational study.
    Breast J. 2019 Aug 25. doi: 10.1111/tbj.13489.
    PubMed     Abstract available


  218. HORWOOD C, Ma N, Hayek J, Terando AM, et al
    Does use of axillary ultrasound in clinically node-negative patients receiving neo-adjuvant systemic therapy for breast cancer lead to surgical overtreatment?
    Breast J. 2019 Aug 21. doi: 10.1111/tbj.13481.
    PubMed     Abstract available


    July 2019
  219. WALLACE AS, Keene KS, Williams CP, Jackson BE, et al
    Hypofractionated radiation in older women with breast cancer.
    Breast J. 2019 Jul 29. doi: 10.1111/tbj.13444.
    PubMed     Abstract available


  220. FARROKH D, Ameri L, Oliaee F, Maftouh M, et al
    Can ultrasound be considered as a potential alternative for sentinel lymph node biopsy for axillary lymph node metastasis detection in breast cancer patients?
    Breast J. 2019 Jul 29. doi: 10.1111/tbj.13475.
    PubMed    


  221. BAEKSTED CW, Nissen A, Knoop A, Christiansen M, et al
    Handling of symptomatic adverse events in breast cancer patients receiving adjuvant chemotherapy in a cluster randomized trial with electronic patient-reported outcomes as intervention.
    Breast J. 2019 Jul 28. doi: 10.1111/tbj.13477.
    PubMed    


  222. THORPE CS, Niska JR, Girardo ME, Kosiorek HE, et al
    Proton beam therapy reirradiation for breast cancer: Multi-institutional prospective PCG registry analysis.
    Breast J. 2019 Jul 23. doi: 10.1111/tbj.13423.
    PubMed     Abstract available


  223. CONFORTI A, Schettini F, Vallone R, Di Rella F, et al
    Unexpected ovarian activity in premenopausal breast cancer survivors treated with exemestane and GnRH analogues.
    Breast J. 2019 Jul 23. doi: 10.1111/tbj.13474.
    PubMed    


  224. FERREIRA DA SILVA F, de Lurdes Orvalho M, Gaspar A, Viana Lopes P, et al
    Preoperative axillary lymph node staging in early breast cancer: Diagnostic efficacy and histopathology correlation.
    Breast J. 2019 Jul 23. doi: 10.1111/tbj.13471.
    PubMed    


  225. SHI ZQ, Qiu PF, Liu YB, Cong BB, et al
    Neo-adjuvant chemotherapy and axillary de-escalation management for patients with clinically node-negative breast cancer.
    Breast J. 2019 Jul 22. doi: 10.1111/tbj.13422.
    PubMed     Abstract available


  226. SHAH C, Ridner SH
    Bioimpedance spectroscopy: The breast cancer survivorship vital sign.
    Breast J. 2019 Jul 22. doi: 10.1111/tbj.13470.
    PubMed    


  227. CASTANEDA CA, Castillo M, Enciso JA, Enciso N, et al
    Role of undifferentiation markers and androgen receptor expression in triple-negative breast cancer.
    Breast J. 2019 Jul 22. doi: 10.1111/tbj.13464.
    PubMed    


  228. LEE GE, Rosenberg SM, Mayer EL, Borges V, et al
    Contemporary management of breast cancer during pregnancy and subsequent lactation in a multicenter cohort of young women with breast cancer.
    Breast J. 2019 Jul 18. doi: 10.1111/tbj.13431.
    PubMed     Abstract available


  229. IWASE M, Hattori M, Sawaki M, Yoshimura A, et al
    Presence of small residual malignant lesions in pathologic complete response after neo-adjuvant chemotherapy in patients with breast cancer.
    Breast J. 2019 Jul 18. doi: 10.1111/tbj.13473.
    PubMed    


  230. KUPSIK M, Sulo S, Katz A, Memmel H, et al
    What do women really think? Patient understanding of breast cancer risk.
    Breast J. 2019 Jul 18. doi: 10.1111/tbj.13472.
    PubMed    


  231. BARCHIESI G, McCartney A, Biagioni C, Siclari O, et al
    Early triple negative breast cancer: Are we getting better outcomes? A retrospective analysis from a single institution.
    Breast J. 2019 Jul 16. doi: 10.1111/tbj.13437.
    PubMed     Abstract available


  232. YIP RHL, Yong-Hing CJ, Farinha PMS, Hayes MM, et al
    Isolated intramammary Kikuchi-Fujimoto disease, a mimic of breast cancer.
    Breast J. 2019 Jul 12. doi: 10.1111/tbj.13466.
    PubMed    


  233. WEI F, Chen W, Lin X
    Efficacy and safety of adjuvant endocrine therapy in premenopausal patients with early-stage hormone receptor-positive breast cancer: A meta-analysis of randomized controlled trials.
    Breast J. 2019 Jul 12. doi: 10.1111/tbj.13465.
    PubMed    


  234. PHADKE S, Vander Weg M, Itani N, Grogan N, et al
    Breast cancer patient preferences for test result communication.
    Breast J. 2019 Jul 12. doi: 10.1111/tbj.13461.
    PubMed    


  235. PATTERSON-LOMBA O, Dalal AA, Ayyagari R, Liu O, et al
    Systematic literature review of clinical trials of endocrine therapies for premenopausal women with metastatic HR+ HER2- breast cancer.
    Breast J. 2019 Jul 9. doi: 10.1111/tbj.13345.
    PubMed     Abstract available


  236. ZNIDARIC T, Gugic J, Marinko T, Gojkovic Horvat A, et al
    Breast cancer patients with brain metastases or leptomeningeal disease: 10-year results of a national cohort with validation of prognostic indexes.
    Breast J. 2019 Jul 8. doi: 10.1111/tbj.13433.
    PubMed     Abstract available


  237. OU D, Cao L, Xu C, Kirova Y, et al
    Upfront brain radiotherapy may improve survival for unfavorable prognostic breast cancer brain metastasis patients with Breast-GPA 0-2.0.
    Breast J. 2019 Jul 8. doi: 10.1111/tbj.13426.
    PubMed     Abstract available


  238. CHOTAI N, Tang S, Lim H, Lu S, et al
    Breast cancer in a female to male transgender patient 20 years post-mastectomy: Issues to consider.
    Breast J. 2019 Jul 4. doi: 10.1111/tbj.13417.
    PubMed     Abstract available


  239. HAQUE W, Verma V, Hsiao KY, Hatch S, et al
    Omission of radiation therapy following breast conservation in older (>/=70 years) women with T1-2N0 triple-negative breast cancer.
    Breast J. 2019 Jul 4. doi: 10.1111/tbj.13443.
    PubMed     Abstract available


  240. BLAES AH, Jewett PI, McKay K, Riley D, et al
    Factors associated with genetic testing in a cohort of breast cancer survivors.
    Breast J. 2019 Jul 3. doi: 10.1111/tbj.13440.
    PubMed     Abstract available


  241. MANYAM BV, Shah C, Woody NM, Reddy CA, et al
    Long-term complications and reconstruction failures in previously radiated breast cancer patients receiving salvage mastectomy with autologous reconstruction or tissue expander/implant-based reconstruction.
    Breast J. 2019 Jul 1. doi: 10.1111/tbj.13428.
    PubMed     Abstract available


  242. DONOVAN E, Dhesy-Thind S, Mukherjee S, Kucharczyk M, et al
    Attitudes and beliefs toward the use of stereotactic body radiotherapy in oligometastatic breast cancer: A commentary on a survey of Canadian Medical Oncologists.
    Breast J. 2019 Jul 1. doi: 10.1111/tbj.13435.
    PubMed     Abstract available


  243. WOOD ME, Garber JE, Isaacs C, Masood S, et al
    Genetic testing for hereditary breast and ovarian cancer and the USPSTF recommendations.
    Breast J. 2019;25:575-577.
    PubMed    


    June 2019
  244. CROWN A, Grumley J
    Biopsy-proven lymph nodes predict axillary nodal response following neoadjuvant chemotherapy in node-positive breast cancer.
    Breast J. 2019 Jun 29. doi: 10.1111/tbj.13412.
    PubMed    


  245. DREYFUSS AD, Barsky AR, Taunk NK, Clark AS, et al
    The efficacy and safety of hypofractionated radiotherapy with concurrent anti-HER-2 therapy following breast-conserving therapy for breast cancer.
    Breast J. 2019 Jun 28. doi: 10.1111/tbj.13421.
    PubMed     Abstract available


  246. PHILLIPS GSA, Gore S, Ramsden A, Furniss D, et al
    Lymphaticovenular anastomosis improves quality of life and limb volume in patients with secondary lymphedema after breast cancer treatment.
    Breast J. 2019 Jun 27. doi: 10.1111/tbj.13348.
    PubMed     Abstract available


  247. BISGIN A, Boga I, Yalav O, Sonmezler O, et al
    BRCA mutation characteristics in a series of index cases of breast cancer selected independent of family history.
    Breast J. 2019 Jun 22. doi: 10.1111/tbj.13400.
    PubMed     Abstract available


  248. LI X, Kong X, Chen S, Jiang L, et al
    Enlarged para-sentinel lymph node dissection is not necessary in breast cancer patients undergoing sentinel lymph node biopsy.
    Breast J. 2019 Jun 17. doi: 10.1111/tbj.13395.
    PubMed    


  249. DIALANI V, Tseng I, Slanetz PJ, Fein-Zachary V, et al
    Potential role of abbreviated MRI for breast cancer screening in an academic medical center.
    Breast J. 2019 Jun 17. doi: 10.1111/tbj.13297.
    PubMed     Abstract available


  250. KANE G, Fleming C, Heneghan H, McCartan D, et al
    False-negative rate of ultrasound-guided fine-needle aspiration cytology for identifying axillary lymph node metastasis in breast cancer patients.
    Breast J. 2019 Jun 13. doi: 10.1111/tbj.13402.
    PubMed     Abstract available


  251. YOON EC, Schwartz C, Brogi E, Ventura K, et al
    Impact of biomarkers and genetic profiling on breast cancer prognostication: A comparative analysis of the 8th edition of breast cancer staging system.
    Breast J. 2019 Jun 13. doi: 10.1111/tbj.13352.
    PubMed     Abstract available


  252. ZHANG J, Zhao B, Jin F
    The assessment of 8th edition AJCC prognostic staging system and a simplified staging system for breast cancer: The analytic results from the SEER database.
    Breast J. 2019 Jun 13. doi: 10.1111/tbj.13347.
    PubMed     Abstract available


  253. KHALLAF E, Abdoon M, Lotfy A, Abdalaziz Y, et al
    Methylene blue 1% as a sensitive and safe alternative for sentinel lymph node biopsy in early stage breast cancer: Results of a large pilot study.
    Breast J. 2019 Jun 13. doi: 10.1111/tbj.13401.
    PubMed    


  254. SU S, Wang C, Wang X, Li X, et al
    Prognostic value of combining lymph node ratio and number of positive lymph nodes in breast cancer: A population-based study.
    Breast J. 2019 Jun 11. doi: 10.1111/tbj.13414.
    PubMed    


  255. MAXWELL J, Shats O, Aldridge J, Lyden E, et al
    The impact of the affordable care act on breast cancer care in the USA: A multi-institutional analysis.
    Breast J. 2019 Jun 11. doi: 10.1111/tbj.13373.
    PubMed     Abstract available


  256. LIM SM, Kim JY, Park HS, Park S, et al
    Effect of primary tumor resection on overall survival in patients with stage IV breast cancer.
    Breast J. 2019 Jun 11. doi: 10.1111/tbj.13344.
    PubMed     Abstract available


  257. AKRAMI M, Arasteh P, Tahmasebi S, Zangouri V, et al
    Response to letter to editor on "Does metaplastic breast carcinoma demonstrate a different clinicopathological behavior in our region: The Shiraz Breast Cancer Registry".
    Breast J. 2019 Jun 11. doi: 10.1111/tbj.13415.
    PubMed    


  258. JAIN AG, Guan J, FaisalUddin M, Manoucheri M, et al
    Improving breast cancer screening rates in a primary care setting.
    Breast J. 2019 Jun 11. doi: 10.1111/tbj.13377.
    PubMed     Abstract available


  259. ALTUNDAG K
    Metaplastic breast cancer: Some concerns about hormone receptor status and treatment schedules.
    Breast J. 2019 Jun 11. doi: 10.1111/tbj.13413.
    PubMed    


  260. DURAES M, Crochet P, Pages E, Grauby E, et al
    Surgery of nonpalpable breast cancer: First step to a virtual per-operative localization? First step to virtual breast cancer localization.
    Breast J. 2019 Jun 9. doi: 10.1111/tbj.13379.
    PubMed     Abstract available


  261. KUDELA E, Nachajova M, Danko J
    Is the HPV virus responsible for the development of breast cancer?
    Breast J. 2019 Jun 6. doi: 10.1111/tbj.13399.
    PubMed    


  262. TOVAR JR, Zandonade E, Amorim MHC
    Local recurrence-free survival in women with breast cancer who undergo breast-conserving surgery.
    Breast J. 2019 Jun 6. doi: 10.1111/tbj.13411.
    PubMed    


  263. SCHREUDER K, Middelburg JG, Aarts MJ, Merkus JWS, et al
    An actualised population-based study on the use of radiotherapy in breast cancer patients in the Netherlands.
    Breast J. 2019 Jun 4. doi: 10.1111/tbj.13376.
    PubMed     Abstract available


  264. LAFON M, Blaye C, Kind M, Bechade D, et al
    Sarcoidosis-like reaction in metastatic triple negative breast cancer treated by anti-PD-L1.
    Breast J. 2019 Jun 4. doi: 10.1111/tbj.13386.
    PubMed     Abstract available


  265. KELEMEN P, Pukancsik D, Ujhelyi M, Kovacs E, et al
    Evaluation of the central pedicled, modified Wise-pattern technique as a standard level II oncoplastic breast-conserving surgery: A retrospective clinicopathological study of 190 breast cancer patients.
    Breast J. 2019 Jun 4. doi: 10.1111/tbj.13371.
    PubMed     Abstract available


  266. REBOUCAS LM, Campos CS, D'Amico GM, Lustosa AB, et al
    Once-weekly hypofractionated radiotherapy for breast cancer: First results of a phase II clinical trial.
    Breast J. 2019 Jun 4. doi: 10.1111/tbj.13372.
    PubMed     Abstract available


  267. KHOSRAVI-SHAHI P, Cabezon-Gutierrez L, Aparicio Salcedo MI
    State of art of advanced triple negative breast cancer.
    Breast J. 2019 Jun 2. doi: 10.1111/tbj.13369.
    PubMed     Abstract available


  268. SADEGHI M, Alamdaran SA, Daneshpajouhnejad P, Layegh P, et al
    A logistic regression nomogram to predict axillary lymph node metastasis in early invasive breast cancer patients.
    Breast J. 2019 Jun 2. doi: 10.1111/tbj.13340.
    PubMed    


  269. BEN KRIDIS W, Toumi N, Ben Salah H, Sghaier S, et al
    Therapeutic results and prognostic factors of brain metastases from breast cancer: Single center experience.
    Breast J. 2019 Jun 2. doi: 10.1111/tbj.13334.
    PubMed    


    May 2019
  270. NGUI NK, Hitos K, Hughes TMD
    Effect of the American College of Surgeons Oncology Group Z0011 trial on axillary management in breast cancer patients in the Australian setting.
    Breast J. 2019 May 27. doi: 10.1111/tbj.13343.
    PubMed     Abstract available


  271. ABDEL-RAHMAN O
    Outcomes of metastatic breast cancer patients in relationship to disease-free interval following primary treatment of localized disease; a pooled analysis of two clinical trials.
    Breast J. 2019 May 27. doi: 10.1111/tbj.13346.
    PubMed     Abstract available


  272. MOUSAVI M, Zargan J, Haji Noor Mohammadi A, Goudarzi HR, et al
    Anticancer effects of the Latrodectus dahli crude venom on MCF-7 breast cancer cell line.
    Breast J. 2019 May 26. doi: 10.1111/tbj.13332.
    PubMed    


  273. PRINSLOO S, Rebello E, Cata JP, Black D, et al
    Electroencephalographic correlates of hypnosedation during breast cancer surgery.
    Breast J. 2019 May 24. doi: 10.1111/tbj.13328.
    PubMed    


  274. LIMA PESSOA E, Costa Vilella Dos Reis M, Sayuri Yamamoto T, Ribeiro Neto M, et al
    Familial heterozygous hypobetalipoproteinemia and breast cancer risk: A systematic review and suggestions for further research.
    Breast J. 2019 May 20. doi: 10.1111/tbj.13341.
    PubMed    


  275. WOOD K, Donnenwirth R, Mills K, Tinsley HN, et al
    Cyclic GMP signaling during human lactation and breast cancer: Implications for breast cancer prevention.
    Breast J. 2019 May 20. doi: 10.1111/tbj.13339.
    PubMed    


  276. ARCIERO C, Liu Y, Gillespie T, Subhedar P, et al
    Surgery and survival in patients with stage IV breast cancer.
    Breast J. 2019 May 13. doi: 10.1111/tbj.13296.
    PubMed     Abstract available


  277. SELLAM Y, Shahadi ID, Gelernter I, Zippel D, et al
    Local recurrence of breast cancer: Salvage lumpectomy as an option for local treatment.
    Breast J. 2019 May 13. doi: 10.1111/tbj.13290.
    PubMed     Abstract available


  278. BAO J, Donovan C, Amersi F, Zhang X, et al
    Outcomes in patients with small node-negative invasive breast cancer.
    Breast J. 2019 May 12. doi: 10.1111/tbj.13288.
    PubMed     Abstract available


  279. PLATKO K, Haas-Neill S, Aziz T, Al-Nedawi K, et al
    The role of circulating extracellular vesicles in breast cancer classification and molecular subtyping.
    Breast J. 2019 May 12. doi: 10.1111/tbj.13309.
    PubMed     Abstract available


  280. KOVAC M, Kovac Z, Tomasevic Z, Tomic B, et al
    Breast cancer and recurrent thrombosis - Results from prospective single center study.
    Breast J. 2019 May 12. doi: 10.1111/tbj.13326.
    PubMed    


  281. COSTA NCD, Morsch DM, Opperman CP, Spritzer PM, et al
    Biological features of breast cancer according to age at diagnosis in southern Brazil: An analysis of retrospective data of 1128 women.
    Breast J. 2019 May 12. doi: 10.1111/tbj.13327.
    PubMed    


  282. YANG K, Park W, Ju SG, Chung Y, et al
    Heart-sparing radiotherapy with three-dimensional printing technology after mastectomy for patients with left breast cancer.
    Breast J. 2019 May 11. doi: 10.1111/tbj.13304.
    PubMed     Abstract available


  283. MILOSEVIC ZC, Nadrljanski MM, Mijalkovic SD
    Sequelae of breast pyoderma gangrenosum associated with ulcerative colitis: Impact on breast cancer screening.
    Breast J. 2019 May 11. doi: 10.1111/tbj.13318.
    PubMed    


  284. ABDEL HADI M
    Breast cancer in developing countries: The shrinking age gap.
    Breast J. 2019 May 9. doi: 10.1111/tbj.13335.
    PubMed    


  285. PATEL A, Wang WJ, Warnack E, Joseph KA, et al
    Surgical treatment of young women with breast cancer: Public vs private hospitals.
    Breast J. 2019 May 9. doi: 10.1111/tbj.13294.
    PubMed     Abstract available


  286. JORIS S, Fontaine C, Decoster L, Vanacker L, et al
    Retrospective comparison of two consecutive cohorts of adjuvant chemotherapy regimens of cyclophosphamide with either docetaxel or paclitaxel in older patients with early breast cancer.
    Breast J. 2019 May 9. doi: 10.1111/tbj.13306.
    PubMed     Abstract available


  287. DUBROVSKY E, Raymond S, Chun J, Fong A, et al
    Genomic testing in early stage invasive male breast cancer: An NCDB analysis from 2008 to 2014.
    Breast J. 2019;25:425-433.
    PubMed     Abstract available


  288. SHREENIVAS A, Shapiro CL
    Central nervous system metastases in triple-negative breast cancer: A step in the right direction.
    Breast J. 2019;25:361-362.
    PubMed    


  289. LUBIAN LOPEZ DM, Castillo Lara M, Rodriguez Rodriguez B, Butron Hinojo CA, et al
    Metabolic syndrome and prognostic factors in postmenopausal breast cancer patients.
    Breast J. 2019;25:548-551.
    PubMed    


  290. IMAMOVIC D, Bilalovic N, Skenderi F, Beslagic V, et al
    Letter to the Editor/Response.
    Breast J. 2019;25:569.
    PubMed    


  291. ALTUNDAG K
    Neo-adjuvant treatment in invasive apocrine carcinoma of the breast.
    Breast J. 2019;25:568.
    PubMed    


  292. ELIA R, Nacchiero E, Vestita M, Giudice G, et al
    "Reply to Letter to the Editor" The post-mastectomy pain syndrome-A systematic review of the treatment modalities.
    Breast J. 2019;25:566-567.
    PubMed    


    April 2019
  293. AMRO A, Chen Y, Barry R, Susick L, et al
    Distribution and Short-term Prognostic Value of the 21-gene recurrence score in African American compared to White American breast cancer patients.
    Breast J. 2019 Apr 25. doi: 10.1111/tbj.13256.
    PubMed     Abstract available


  294. JAKUBOWICZ E, Martin B, Hoffmann R, Kroncke T, et al
    EndoPredict versus uPA/PAI-1 in breast cancer: Comparison of markers and association with clinicopathological parameters.
    Breast J. 2019 Apr 18. doi: 10.1111/tbj.13258.
    PubMed     Abstract available


  295. CAPANEMA SALIBA FRANCO R, Salvador Silva HM, Faria Almeida LL, Drummond-Lage AP, et al
    Sentinel lymph node prognosis value in breast cancer.
    Breast J. 2019 Apr 15. doi: 10.1111/tbj.13271.
    PubMed    


  296. RIBA LA, Gruner RA, Alapati A, James TA, et al
    Association between socioeconomic factors and outcomes in breast cancer.
    Breast J. 2019 Apr 15. doi: 10.1111/tbj.13250.
    PubMed     Abstract available


  297. KOLACINSKA A, Herman K, Morawiec J, Paszek S, et al
    Improvement in outcomes of breast cancer patient treatment in Poland in the 21st century.
    Breast J. 2019 Apr 13. doi: 10.1111/tbj.13245.
    PubMed     Abstract available


  298. ZIAEEMEHR A, Shahidsales S, Ghosi Z, Avan A, et al
    Association of the involvement of axillary lymph nodes in HER-2/neu overexpression in patients with breast cancer.
    Breast J. 2019 Apr 11. doi: 10.1111/tbj.13282.
    PubMed    


  299. BASCH CH, MacLean SA, Garcia P, Basch CE, et al
    Readability of online breast cancer information.
    Breast J. 2019 Apr 10. doi: 10.1111/tbj.13276.
    PubMed    


  300. SOUKIAZIAN A, Hicks DG, Turner BM
    Reconsidering "low-risk" criteria for breast cancer recurrence in hormone positive patients.
    Breast J. 2019 Apr 10. doi: 10.1111/tbj.13275.
    PubMed    


  301. PORIES SE, Myers LE, Dusenbery KL, Lotz M, et al
    Simplifying surveillance for breast cancer survivors.
    Breast J. 2019 Apr 7. doi: 10.1111/tbj.13266.
    PubMed    


  302. HUNT KN, Swanson T, O'Connor MK, Sandhu NP, et al
    Detection of multicentric breast cancer using dedicated breast PET.
    Breast J. 2019 Apr 6. doi: 10.1111/tbj.13270.
    PubMed    


  303. SHAH C, Vicini F
    Accelerated partial breast irradiation-Redefining the treatment target for women with early stage breast cancer.
    Breast J. 2019 Apr 4. doi: 10.1111/tbj.13241.
    PubMed     Abstract available


  304. LEINERT E, Schwentner L, Blettner M, Wockel A, et al
    Association between cognitive impairment and guideline adherence for application of chemotherapy in older patients with breast cancer: Results from the prospective multicenter BRENDA II study.
    Breast J. 2019 Apr 3. doi: 10.1111/tbj.13231.
    PubMed     Abstract available


  305. WANG ZH, Ng HI, Teng CS, Ge ZC, et al
    Outcomes of single-port gasless laparoscopic breast-conserving surgery for breast cancer: An observational study.
    Breast J. 2019 Apr 3. doi: 10.1111/tbj.13249.
    PubMed     Abstract available


    March 2019
  306. KOZAK MM, Xiang M, Pollom EL, Horst KC, et al
    Adjuvant treatment and survival in older women with triple negative breast cancer: A Surveillance, Epidemiology, and End Results analysis.
    Breast J. 2019 Mar 29. doi: 10.1111/tbj.13251.
    PubMed     Abstract available


  307. GABANI P, Weiner AA, Hernandez-Aya LF, Khwaja S, et al
    Treatment response as predictor for brain metastasis in triple negative breast cancer: A score-based model.
    Breast J. 2019 Mar 28. doi: 10.1111/tbj.13230.
    PubMed     Abstract available


  308. ARENA V, Pennacchia I, Vecchio FM, Carbone A, et al
    ER-/PR+/HER2- breast cancer type shows the highest proliferative activity among all other combined phenotypes and is more common in young patients: Experience with 6643 breast cancer cases.
    Breast J. 2019 Mar 27. doi: 10.1111/tbj.13236.
    PubMed     Abstract available


  309. ANAMPA JD, McEvoy MP, Feldman S, Sparano JA, et al
    Applying the Hippocratic Oath in breast cancer-The case for promoting prevention.
    Breast J. 2019;25:187-189.
    PubMed    


    February 2019
  310. MARIANI G, Galli G, Cavalieri S, Valagussa P, et al
    Single Institution trial of anthracycline- and taxane-based chemotherapy for operable breast cancer: The ASTER study.
    Breast J. 2019 Feb 27. doi: 10.1111/tbj.13197.
    PubMed     Abstract available


  311. SWEETING RS, Du L, Shyr Y, Hooks MA, et al
    Income, costs, and health care utilization may influence surgical choice in early stage breast cancer.
    Breast J. 2019 Feb 25. doi: 10.1111/tbj.13223.
    PubMed    


  312. TONG M, Guo W
    Indocyanine green fluorescence-guided lumpectomy of nonpalpable breast cancer versus wire-guided excision: A randomized clinical trial.
    Breast J. 2019 Feb 22. doi: 10.1111/tbj.13207.
    PubMed     Abstract available


  313. DEFAZIO MV, Graziano FD, Lakhiani C, Pittman TA, et al
    Incidental discovery of partial Poland's sequence during mastectomy for contralateral breast cancer.
    Breast J. 2019 Feb 22. doi: 10.1111/tbj.13210.
    PubMed    


  314. LATOSINSKY S, Jenkyn KMB, Li L, Shariff SZ, et al
    Post-mastectomy radiation in node-positive breast cancer in Ontario.
    Breast J. 2019 Feb 21. doi: 10.1111/tbj.13208.
    PubMed     Abstract available


  315. KEMP E, Koczwara B, Turner J, Girgis A, et al
    Internet use and preferences among women living with advanced breast cancer.
    Breast J. 2019 Feb 21. doi: 10.1111/tbj.13203.
    PubMed     Abstract available


  316. VOHRA NA, Brinkley J, Kachare S, Muzaffar M, et al
    Reply to "Letter to the Editor" intent of surgery of the primary tumor in metastatic breast cancer remains palliative.
    Breast J. 2019 Feb 13. doi: 10.1111/tbj.13225.
    PubMed    


  317. NAIR NS, Parmar V, Badwe RA
    Intent of surgery of the primary tumor in metastatic breast cancer remains palliative.
    Breast J. 2019 Feb 13. doi: 10.1111/tbj.13224.
    PubMed    


  318. ROBERSON PNE, Southerland A, Mitchel H, Lloyd J, et al
    Factors predicting medication prescription adherence in Appalachian breast cancer patients.
    Breast J. 2019 Feb 13. doi: 10.1111/tbj.13227.
    PubMed    


  319. PAPPOT H, Baeksted C, Knoop A, Mitchell SA, et al
    Routine surveillance for symptomatic toxicities with real-time clinician reporting in Danish breast cancer patients-Organization and design of the first national, cluster randomized trial using the Patient-Reported Outcomes version of Common Terminolo
    Breast J. 2019 Feb 13. doi: 10.1111/tbj.13204.
    PubMed     Abstract available


  320. AL ALI A, Garrido I, Le Guellec S, Duazo-Cassin L, et al
    Rapidly growing breast desmoid tumor with intra-thoracic involvement after reconstructive surgery for breast cancer.
    Breast J. 2019 Feb 12. doi: 10.1111/tbj.13212.
    PubMed     Abstract available


  321. MANSO L, Moreno Anton F, Izarzugaza Peron Y, Delgado Mingorance JI, et al
    Safety of eribulin as third-line chemotherapy in HER2-negative, advanced breast cancer pre-treated with taxanes and anthracycline: OnSITE study.
    Breast J. 2019 Feb 8. doi: 10.1111/tbj.13199.
    PubMed     Abstract available


  322. CERBELLI B, Botticelli A, Pisano A, Campagna D, et al
    Breast cancer subtypes affect the nodal response after neoadjuvant chemotherapy in locally advanced breast cancer: Are we ready to endorse axillary conservation?
    Breast J. 2019 Feb 7. doi: 10.1111/tbj.13206.
    PubMed     Abstract available


  323. JUNG N, Kim HJ, Jung JH, Lee SW, et al
    Restaging the axilla after neo-adjuvant chemotherapy for breast cancer: Predictive factors for residual metastatic lymph node disease with negative imaging findings.
    Breast J. 2019 Feb 3. doi: 10.1111/tbj.13192.
    PubMed     Abstract available


    January 2019
  324. CHIANG PH, Tang FH, Tsai EM, Chang YC, et al
    Hormone therapy as risk factor of breast cancer modulated by diagnostic and lifestyle risk factors in Taiwan-A National Cohort study.
    Breast J. 2019 Jan 30. doi: 10.1111/tbj.13184.
    PubMed    


  325. KATAOKA A, Sawaki M, Okumura S, Onishi S, et al
    Prediction of pathological margin status using preoperative contrast-enhanced MRI in patients with early breast cancer who underwent skin-sparing mastectomy.
    Breast J. 2019 Jan 30. doi: 10.1111/tbj.13194.
    PubMed     Abstract available


  326. KIM YJ, Shin HJ, Choi ME, Lee WJ, et al
    Radiation dermatitis with foreign body reaction clinically mimics a cutaneous metastasis from breast cancer.
    Breast J. 2019;25:141-142.
    PubMed    


  327. KLAR N, Brufsky A
    Extended adjuvant therapy for early-stage breast cancer: Are there markers for its use?
    Breast J. 2019;25:7-8.
    PubMed    


  328. ABDULLAH N, O'Leary DP, Hegarty A, Albathali M, et al
    The effect of surgical site infection in immediate breast reconstruction on breast cancer recurrence.
    Breast J. 2019;25:166-168.
    PubMed    


    December 2018
  329. PEDDI P, Master SR, Dwary AD, Ravipati HP, et al
    Utility of routine pretreatment evaluation of left ventricular ejection fraction in breast cancer patients receiving anthracyclines.
    Breast J. 2018 Dec 27. doi: 10.1111/tbj.13182.
    PubMed     Abstract available


  330. LOH Z, Yeo B, Williams DS, Gyorki DE, et al
    Ectopic breast cancer in the inguinal region.
    Breast J. 2018 Dec 27. doi: 10.1111/tbj.13177.
    PubMed    


  331. AKRAMI M, Arasteh P, Mokhtari M, Tahmasebi S, et al
    Does metaplastic breast carcinoma demonstrate a different clinicopathological behavior in our region: The Shiraz Breast Cancer Registry.
    Breast J. 2018 Dec 27. doi: 10.1111/tbj.13183.
    PubMed    


  332. OLIVEIRA NPD, Guedes TSR, Holanda AM, Reis MA, et al
    Influence of social conditions on the quality of life of female breast cancer survivors.
    Breast J. 2018 Dec 17. doi: 10.1111/tbj.13181.
    PubMed    


  333. BHANDARI A, Xia E, Wang Y, Wang O, et al
    Laparoscopy-assisted sentinel lymph node dissection in breast cancer patients.
    Breast J. 2018 Dec 14. doi: 10.1111/tbj.13172.
    PubMed    


  334. O'DELL W, Takita C, Casey-Sawicki K, Daily K, et al
    Projected clinical benefit of surveillance imaging for early detection and treatment of breast cancer metastases.
    Breast J. 2018 Dec 12. doi: 10.1111/tbj.13153.
    PubMed     Abstract available


  335. SUTHERLAND S, Meiser B, Kaur R, Mitchell G, et al
    Assessing the medical workforces perceived barriers to the prescription of risk-reducing medication for women at high-risk of breast cancer.
    Breast J. 2018 Dec 7. doi: 10.1111/tbj.13157.
    PubMed     Abstract available


  336. CAO L, G Adedjouma N, Xu C, Shen KW, et al
    The role of post-mastectomy radiotherapy in elderly patients with 1-3 positive lymph nodes breast cancer: An International Retrospective Double-Center Study.
    Breast J. 2018 Dec 6. doi: 10.1111/tbj.13163.
    PubMed     Abstract available


  337. LOVASIK BP, Seidel RL, Novello M, Torres MA, et al
    Single incision for oncologic breast conserving surgery and sentinel node biopsy in early stage breast cancer: A minimally invasive approach.
    Breast J. 2018 Dec 3. doi: 10.1111/tbj.13158.
    PubMed     Abstract available


    November 2018
  338. REBLIN M, Kasting ML, Nam K, Scherr CL, et al
    Health beliefs associated with readiness for genetic counseling among high risk breast cancer survivors.
    Breast J. 2018 Nov 28. doi: 10.1111/tbj.13165.
    PubMed     Abstract available


  339. GUVENC I, Whitman GJ, Liu P, Yalniz C, et al
    Diffusion-weighted MR imaging increases diagnostic accuracy of breast MR imaging for predicting axillary metastases in breast cancer patients.
    Breast J. 2018 Nov 16. doi: 10.1111/tbj.13151.
    PubMed     Abstract available


  340. OZKURT E, Yardimci E, Tukenmez M, Ersoy YE, et al
    Intraoperative palpation of sentinel lymph nodes can accurately predict axilla in early breast cancer.
    Breast J. 2018 Nov 12. doi: 10.1111/tbj.13149.
    PubMed     Abstract available


  341. SHECHTER MAOR G, Czuzoj-Shulman N, Spence AR, Abenhaim HA, et al
    Neonatal outcomes of pregnancy-associated breast cancer: Population-based study on 11 million births.
    Breast J. 2018 Nov 12. doi: 10.1111/tbj.13156.
    PubMed     Abstract available


  342. ASAGA S, Kinoshita T, Shiino S, Jimbo K, et al
    Prognostic factors for breast cancer patients with T1-2 tumor and 1-3 positive axillary nodes treated using total mastectomy without radiotherapy.
    Breast J. 2018 Nov 9. doi: 10.1111/tbj.13148.
    PubMed     Abstract available


  343. HUNTER-SQUIRES J, Giuliano AE
    Biopsy of abnormal intramammary and axillary lymph nodes in patients without breast cancer.
    Breast J. 2018;24:867-868.
    PubMed    


  344. JEON W, Jang BS, Jeon SH, Kim JH, et al
    Analysis of survival outcomes based on molecular subtypes in breast cancer brain metastases: A single institutional cohort.
    Breast J. 2018;24:920-926.
    PubMed     Abstract available


    October 2018
  345. MAZOUNI C, Koual M, De Leeuw F, Conversano A, et al
    Prospective evaluation of the limitations of near-infrared imaging in detecting axillary sentinel lymph nodes in primary breast cancer.
    Breast J. 2018 Oct 8. doi: 10.1111/tbj.13123.
    PubMed     Abstract available


  346. SURMELI ZG
    Primary tumor resection in metastatic breast cancer: A propensity-matched analysis, 1988-2011 SEER data base.
    Breast J. 2018 Oct 7. doi: 10.1111/tbj.13145.
    PubMed    


  347. CROCE MV, Cermignani L, Rabassa ME, Segal-Eiras A, et al
    Factors associated with breast cancer in an Argentine city.
    Breast J. 2018 Oct 4. doi: 10.1111/tbj.13147.
    PubMed    


    September 2018
  348. MESHKAT M, Baghestani AR, Zayeri F, Khayamzadeh M, et al
    Survival probability and prognostic factors of Iranian breast cancer patients using cure rate model.
    Breast J. 2018 Sep 30. doi: 10.1111/tbj.13120.
    PubMed     Abstract available


  349. HENNEGHAN A, Phillips C, Courtney A
    We are different: Young adult survivors' experience of breast cancer.
    Breast J. 2018 Sep 27. doi: 10.1111/tbj.13128.
    PubMed    


  350. CURREY A, Patten CR, Bergom C, Wilson JF, et al
    Management of the axilla after neo-adjuvant chemotherapy for breast cancer: Sentinel node biopsy and radiotherapy considerations.
    Breast J. 2018 Sep 25. doi: 10.1111/tbj.13116.
    PubMed     Abstract available


  351. CRISPIN M, Udovicich C, Chan S, Wong S, et al
    Trends in genetic screening referral in breast cancer patients under the age of forty: 2001-2016.
    Breast J. 2018 Sep 24. doi: 10.1111/tbj.13130.
    PubMed    


  352. DOS SANTOS FIGUEIREDO FW, Schoueri JHM, Almeida TCDC, de Carvalho LEW, et al
    Risk factors for breast cancer mortality: Evidence from Brazil.
    Breast J. 2018 Sep 21. doi: 10.1111/tbj.13144.
    PubMed    


  353. WILSON PC, Chagpar AB, Cicek AF, Bossuyt V, et al
    Breast cancer histopathology is predictive of low-risk Oncotype Dx recurrence score.
    Breast J. 2018 Sep 19. doi: 10.1111/tbj.13117.
    PubMed     Abstract available


  354. HOU Y, Nitta H, Wei L, Banks PM, et al
    PD-L1 expression and CD8-positive T cells are associated with favorable survival in HER2-positive invasive breast cancer.
    Breast J. 2018 Sep 19. doi: 10.1111/tbj.13112.
    PubMed     Abstract available


  355. BRADLEY JA
    The current status of intraoperative radiation therapy in breast cancer: Challenges and promises.
    Breast J. 2018;24:713-714.
    PubMed    


    August 2018
  356. TAKUWA H, Hagiwara R, Takahara S, Yamauchi A, et al
    Assisted reproductive technology is effective for but does not affect the prognosis of young patients with breast cancer: Experience in a single institution.
    Breast J. 2018 Aug 16. doi: 10.1111/tbj.13083.
    PubMed     Abstract available


  357. YANG M, Barker K, Goodman D, Park HL, et al
    Effective risk communication to promote behavioral change in patients at elevated risk for breast cancer based on the Health Belief Model.
    Breast J. 2018 Aug 6. doi: 10.1111/tbj.13086.
    PubMed    


  358. POP CF, Stanciu-Pop C, Drisis S, Radermeker M, et al
    The impact of breast MRI workup on tumor size assessment and surgical planning in patients with early breast cancer.
    Breast J. 2018 Aug 3. doi: 10.1111/tbj.13104.
    PubMed     Abstract available


    July 2018
  359. PATEL S, Delikat A, Liao J, Chetlen AL, et al
    Pre- and post-magnetic resonance imaging features of suspicious internal mammary lymph nodes in breast cancer patients receiving neo-adjuvant therapy: Are any imaging features predictive of malignancy?
    Breast J. 2018 Jul 31. doi: 10.1111/tbj.13102.
    PubMed     Abstract available


  360. LOI M, Desideri I, Olmetto E, Francolini G, et al
    BRCA mutation in breast cancer patients: Prognostic impact and implications on clinical management.
    Breast J. 2018 Jul 31. doi: 10.1111/tbj.13100.
    PubMed     Abstract available


  361. SOARES LR, Freitas-Junior R
    The impact of mammography screening on the surgical treatment of breast cancer.
    Breast J. 2018 Jul 30. doi: 10.1111/tbj.13093.
    PubMed    


  362. HANNAN E, Peter O'Leary D, Cheung C, Buhamad F, et al
    Knowledge of breast cancer risk factors, screening, and treatment methods in patients attending the breast clinic: A survey of 1,018 women.
    Breast J. 2018 Jul 30. doi: 10.1111/tbj.13082.
    PubMed    


  363. MANNU GS, Gammer B, Bettencourt-Silva JH, Tsoti SM, et al
    Prognostic factors for male breast cancer: A breast center's 10-year experience.
    Breast J. 2018 Jul 30. doi: 10.1111/tbj.13081.
    PubMed    


  364. TJALMA WAA
    When to perform a sentinel node biopsy in breast cancer patients undergoing neo-adjuvant chemotherapy?
    Breast J. 2018 Jul 26. doi: 10.1111/tbj.13088.
    PubMed    


  365. ALTUNDAG K
    Extent of metastases other than brain metastases may affect outcome in a breast cancer patients underwent resection of a brain metastases.
    Breast J. 2018 Jul 26. doi: 10.1111/tbj.13094.
    PubMed    


  366. VUGTS G, Van den Heuvel F, Maaskant-Braat AJG, Voogd AC, et al
    Predicting breast and axillary response after neoadjuvant treatment for breast cancer: The role of histology vs receptor status.
    Breast J. 2018 Jul 22. doi: 10.1111/tbj.13085.
    PubMed     Abstract available


  367. AZIM HA, Lasheen S, Kassem L
    Treatment of HER2-positive early breast cancer: How to best balance efficacy and toxicity?
    Breast J. 2018;24:459-461.
    PubMed    


    May 2018
  368. MELNOV S, Murphy P, Foley T, Nadyrov E, et al
    Somatic hematopoietic TP53 mosaicism in women with breast cancer exposed to ionizing radiation.
    Breast J. 2018 May 21. doi: 10.1111/tbj.13056.
    PubMed    


  369. CAUGHRAN J, Braun TM, Breslin TM, Smith DR, et al
    The Effect of the 2009 USPSTF breast cancer screening recommendations on breast cancer in Michigan: A longitudinal study.
    Breast J. 2018 May 21. doi: 10.1111/tbj.13034.
    PubMed     Abstract available


  370. MANSOORI Y, Tabei MB, Askari A, Izadi P, et al
    Expression levels of breast cancer-related GAS5 and LSINCT5 lncRNAs in cancer-free breast tissue: Molecular associations with age at menarche and obesity.
    Breast J. 2018 May 21. doi: 10.1111/tbj.13067.
    PubMed     Abstract available


  371. BALAGAMWALA EH, Manyam BV, Leyrer CM, Karthik N, et al
    Most patients are eligible for an alternative to conventional whole breast irradiation for early-stage breast cancer: A National Cancer Database Analysis.
    Breast J. 2018 May 20. doi: 10.1111/tbj.13051.
    PubMed     Abstract available


  372. MARIANI M, George K
    Neuropsychological and self-reporting outcomes following rehabilitation of cognitive dysfunction in survivors of breast cancer: A pilot study involving survivor-partner dyads.
    Breast J. 2018 May 20. doi: 10.1111/tbj.13060.
    PubMed    


  373. BELAID I, Fatma LB, Ezzairi F, Hochlaf M, et al
    Trends and current challenges of breast cancer in Tunisia: a retrospective study of 1262 cases with survival analysis.
    Breast J. 2018 May 20. doi: 10.1111/tbj.13062.
    PubMed    


  374. WHITE MC, Soman A, Weinberg CR, Rodriguez JL, et al
    Factors associated with breast MRI use among women with a family history of breast cancer.
    Breast J. 2018 May 20. doi: 10.1111/tbj.13063.
    PubMed     Abstract available


  375. KODAGANUR S, Paga U, Ram A, Krishna A, et al
    Feasibility, safety, and clinical outcomes following latissimus dorsi flap reconstruction in breast cancer- an Institutional study.
    Breast J. 2018 May 8. doi: 10.1111/tbj.13059.
    PubMed    


  376. MCCORMICK B
    It is time to personalize local treatment options for women with "good risk" DCIS.
    Breast J. 2018;24:231-232.
    PubMed    


  377. CAVIGGIOLI F, Klinger F, Lisa A, Rimondo A, et al
    The post-mastectomy pain syndrome-A systematic review of the treatment modalities.
    Breast J. 2018;24:451-452.
    PubMed    


    April 2018
  378. MURATA T, Jinno H, Takahashi M, Shimoda M, et al
    Clinicopathologic features of hormone-receptor-positive breast cancer patients with late recurrence.
    Breast J. 2018 Apr 23. doi: 10.1111/tbj.13033.
    PubMed     Abstract available


  379. LARSON KE, Grobmyer SR, Valente SA
    Evaluation of recurrence patterns and survival in modern series of young women with breast cancer.
    Breast J. 2018 Apr 23. doi: 10.1111/tbj.13041.
    PubMed     Abstract available


  380. JIANG Z, Yang Y, Li S, Pan Z, et al
    A case of tonsillar metastasis from breast cancer and literature review.
    Breast J. 2018 Apr 23. doi: 10.1111/tbj.13045.
    PubMed    


  381. KAIDAR-PERSON O, Marks LB, Jones EL
    Pentoxifylline and vitamin E for treatment or prevention of radiation-induced fibrosis in patients with breast cancer.
    Breast J. 2018 Apr 23. doi: 10.1111/tbj.13044.
    PubMed     Abstract available


  382. SCHNAPPER G, Marotti L, Casella D, Mano MP, et al
    Data managers: A survey of the European Society of Breast Cancer Specialists in certified multi-disciplinary breast centers.
    Breast J. 2018 Apr 23. doi: 10.1111/tbj.13043.
    PubMed     Abstract available


    March 2018
  383. YOON HJ, Kim Y, Chung J, Kim BS, et al
    Predicting neo-adjuvant chemotherapy response and progression-free survival of locally advanced breast cancer using textural features of intratumoral heterogeneity on F-18 FDG PET/CT and diffusion-weighted MR imaging.
    Breast J. 2018 Mar 30. doi: 10.1111/tbj.13032.
    PubMed     Abstract available


  384. KIM R, Kawai A, Wakisaka M, Funaoka Y, et al
    Outcomes of outpatient breast cancer surgery at a private breast clinic.
    Breast J. 2018 Mar 14. doi: 10.1111/tbj.13012.
    PubMed     Abstract available


  385. KEIM-MALPASS J, Doede A, Camacho F, Kennedy C, et al
    Impact of patient health literacy on surgical treatment of breast cancer.
    Breast J. 2018 Mar 14. doi: 10.1111/tbj.13011.
    PubMed     Abstract available


  386. CHO E, Wu Q, Rubinstein L, Linden H, et al
    Adjuvant continuous metronomic adriamycin + cyclophosphamide followed by weekly nab-paclitaxel for high-risk early-stage breast cancer.
    Breast J. 2018 Mar 13. doi: 10.1111/tbj.13013.
    PubMed     Abstract available


  387. HANLEY BP, Walsh SM, O'Leary DP, MacNally SP, et al
    The significance of receptor status discordance between breast cancer primary and brain metastasis.
    Breast J. 2018 Mar 8. doi: 10.1111/tbj.13028.
    PubMed    


  388. DIALANI V, Westra C, Venkataraman S, Fein-Zachary V, et al
    Indications for biopsy of imaging-detected intramammary and axillary lymph nodes in the absence of concurrent breast cancer.
    Breast J. 2018 Mar 8. doi: 10.1111/tbj.13009.
    PubMed     Abstract available


  389. VIEIRA RADC, Silveira SFDS, Silva DRD, Tramonte MS, et al
    Knowledge and attitudes about breast cancer care in female inmates in Sao Paulo State/Brazil.
    Breast J. 2018 Mar 8. doi: 10.1111/tbj.13025.
    PubMed    


  390. BARCO I, Fraile M, Vidal M, Cambra MJ, et al
    Tamoxifen induced radiation recall dermatitis in a breast cancer patient.
    Breast J. 2018 Mar 8. doi: 10.1111/tbj.13014.
    PubMed    


  391. O'SHEA E, O'Reilly S, Smiddy P
    Rare imaging appearance of skeletal metastases in a 61-year-old breast cancer patient.
    Breast J. 2018 Mar 2. doi: 10.1111/tbj.13019.
    PubMed    


  392. CLIFTON K, Barnett C, Martinez A, Karuturi M, et al
    Severe hyponatremia following cyclophosphamide infusion in breast cancer patients.
    Breast J. 2018 Mar 2. doi: 10.1111/tbj.13026.
    PubMed    


  393. KAMAL M, Nafie EHO, Elsers S, Alanwar S, et al
    Ethnicity influences breast cancer stem cells' drug resistance.
    Breast J. 2018 Mar 2. doi: 10.1111/tbj.13021.
    PubMed    


  394. VOHRA NA, Brinkley J, Kachare S, Muzaffar M, et al
    Primary tumor resection in metastatic breast cancer: A propensity-matched analysis, 1988-2011 SEER data base.
    Breast J. 2018 Mar 2. doi: 10.1111/tbj.13005.
    PubMed     Abstract available


  395. TOZBIKIAN GH, Zynger DL
    HER2 equivocal breast cancer that is positive by alternative probe HER2 FISH are classified as HER2 negative by Oncotype DX.
    Breast J. 2018 Mar 2. doi: 10.1111/tbj.13004.
    PubMed     Abstract available


  396. SMITH IORFIDO SM, Makariou E
    Empyema necessitans mimicking inflammatory breast cancer-An unusual case of breast edema.
    Breast J. 2018 Mar 2. doi: 10.1111/tbj.13015.
    PubMed    


  397. YADAV S, Jinna S, Pereira-Rodrigues O, Reeves A, et al
    Impact of preoperative BRCA1/2 testing on surgical decision making in patients with newly diagnosed breast cancer.
    Breast J. 2018 Mar 2. doi: 10.1111/tbj.13007.
    PubMed     Abstract available


  398. UNKART JT, Proudfoot J, Wallace AM
    Outcomes of "one-day" vs "two-day" injection protocols using Tc-99m tilmanocept for sentinel lymph node biopsy in breast cancer.
    Breast J. 2018 Mar 2. doi: 10.1111/tbj.13002.
    PubMed     Abstract available


  399. BORDERS MH
    Breast MRI and BI-RADS category 3: Is it appropriate?
    Breast J. 2018;24:107-108.
    PubMed    


  400. NADEEM R
    Prepectoral implant-based breast reconstruction; complete acellular dermal matrix wrap or anterior circumferential cover.
    Breast J. 2018;24:223-224.
    PubMed    


    February 2018
  401. NOWIKIEWICZ T, Zegarski W, Pagacz K, Nowacki M, et al
    Does the presence of sentinel lymph node macrometastases in breast cancer patients require axillary lymph node dissection?-Single-center analysis.
    Breast J. 2018 Feb 24. doi: 10.1111/tbj.12997.
    PubMed     Abstract available


  402. CAMPBELL A, Heydarian R, Ochoa C, Dwivedi AK, et al
    Single arm phase II study of oral vitamin B12 for the treatment of musculoskeletal symptoms associated with aromatase inhibitors in women with early stage breast cancer.
    Breast J. 2018 Feb 14. doi: 10.1111/tbj.12951.
    PubMed     Abstract available


  403. SWINTELSKI C, Plaza M
    Successful cryoablation of breast cancer.
    Breast J. 2018 Feb 7. doi: 10.1111/tbj.12996.
    PubMed     Abstract available


    January 2018
  404. WEINER A, D'Andrea GM
    Hidden estrogen production from ovarian remnants leading to progression of disease in metastatic breast cancer.
    Breast J. 2018 Jan 22. doi: 10.1111/tbj.12972.
    PubMed     Abstract available


  405. BARROU J, Tallet A, Cohen M, Bannier M, et al
    Contribution of intraoperative radiotherapy (IORT) for therapeutic de-escalation in early breast cancer: Report of a single institution's experience.
    Breast J. 2018 Jan 22. doi: 10.1111/tbj.12993.
    PubMed     Abstract available


  406. COOPEY SB, Acar A, Griffin M, Cintolo-Gonzalez J, et al
    The impact of patient age on breast cancer risk prediction models.
    Breast J. 2018 Jan 8. doi: 10.1111/tbj.12976.
    PubMed     Abstract available


    December 2017
  407. DECOSTER L, Fontaine C, Vanacker L, Schallier D, et al
    Docetaxel/cyclophosphamide chemotherapy in older patients with breast cancer.
    Breast J. 2017 Dec 29. doi: 10.1111/tbj.12990.
    PubMed    


  408. GARG M, Prabhakar N, Singla V, Singh T, et al
    Breast cancer in a patient with neurofibromatosis type 1.
    Breast J. 2017 Dec 29. doi: 10.1111/tbj.12987.
    PubMed    


  409. FONSECA V, Brito M
    Starting hormone therapy immediately after histological diagnosis of breast cancer.
    Breast J. 2017 Dec 29. doi: 10.1111/tbj.12995.
    PubMed    


  410. MERCKEL LG, Verburg E, van der Velden BHM, Loo CE, et al
    Eligibility of patients for minimally invasive breast cancer therapy based on MRI analysis of tumor proximity to skin and pectoral muscle.
    Breast J. 2017 Dec 29. doi: 10.1111/tbj.12984.
    PubMed     Abstract available


  411. MARTIN-ROMANO P, Baraibar I, Espinos J, Legaspi J, et al
    Combination of pegylated liposomal doxorubicin plus gemcitabine in heavily pretreated metastatic breast cancer patients: Long-term results from a single institution experience.
    Breast J. 2017 Dec 29. doi: 10.1111/tbj.12975.
    PubMed     Abstract available


  412. HWANG E, Yap ML, Boxer MM, Chong S, et al
    Variations in breast cancer histology and treatment patterns between the major ethnic groups of South West Sydney.
    Breast J. 2017 Dec 19. doi: 10.1111/tbj.12973.
    PubMed     Abstract available


  413. PASRICHA S, Gupta G, Garg R, Sharma A, et al
    Impact of 2013 ASCO/CAP HER2 reporting guidelines in breast cancer: An assessment study from Indian oncology centre that primarily performs HER2 IHC testing with special emphasis on IHC equivocal category.
    Breast J. 2017 Dec 18. doi: 10.1111/tbj.12981.
    PubMed     Abstract available


  414. KAIDAR-PERSON O, Deal AM, Anders CK, Ewend MG, et al
    The incidence and predictive factors for leptomeningeal spread after stereotactic radiation for breast cancer brain metastases.
    Breast J. 2017 Dec 18. doi: 10.1111/tbj.12919.
    PubMed    


  415. KUMAR RV, Bhasker S
    A peek into epidemiology, screening, management of breast cancer in developing countries: Experience from two regional cancer centers in India.
    Breast J. 2017 Dec 5. doi: 10.1111/tbj.12965.
    PubMed    


  416. BAYO J, Avino V, Toscano F, Jimenez F, et al
    Toxicity of docetaxel, carboplatin, and trastuzumab combination as adjuvant or neo-adjuvant treatment for Her2 positive breast cancer patients and impact of colony-stimulating factor prophylaxis.
    Breast J. 2017 Dec 5. doi: 10.1111/tbj.12927.
    PubMed     Abstract available


    November 2017
  417. LI T, Tang L, Gandomkar Z, Heard R, et al
    Mammographic density and other risk factors for breast cancer among women in China.
    Breast J. 2017 Nov 29. doi: 10.1111/tbj.12967.
    PubMed    


  418. WEINBERG MS, Shachar SS, Muss HB, Deal AM, et al
    Beyond sarcopenia: Characterization and integration of skeletal muscle quantity and radiodensity in a curable breast cancer population.
    Breast J. 2017 Nov 15. doi: 10.1111/tbj.12952.
    PubMed     Abstract available


  419. PASSHAK M, Shachar SS, Bar-Sela G, Fried G, et al
    Breast cancer in young women aged 35 and under: Patterns of care and outcome.
    Breast J. 2017 Nov 15. doi: 10.1111/tbj.12966.
    PubMed    


  420. HLUBOCKY J, Bhavnagri S, Swinford A, Mitri C, et al
    Does the use of pretreatment MRI change the management of patients with newly diagnosed breast cancer?
    Breast J. 2017 Nov 5. doi: 10.1111/tbj.12946.
    PubMed     Abstract available


  421. SALERNO C, Vento AR, Giacchino M, Lissidini G, et al
    Intra-operative radiotherapy management for breast cancer treatment in patients with pseudoxanthoma elasticum: A case report.
    Breast J. 2017 Nov 5. doi: 10.1111/tbj.12944.
    PubMed     Abstract available


  422. SHAGISULTANOVA E, Mayordomo J, Elias AD
    Triple-negative breast cancer in the elderly.
    Breast J. 2017;23:627-629.
    PubMed    


    October 2017
  423. WHITWORTH PW, Cooper A
    Reducing chronic breast cancer-related lymphedema utilizing a program of prospective surveillance with bioimpedance spectroscopy.
    Breast J. 2017 Oct 24. doi: 10.1111/tbj.12939.
    PubMed     Abstract available


  424. MERRILL RM
    Conditional relative survival among female breast cancer patients in the United States.
    Breast J. 2017 Oct 24. doi: 10.1111/tbj.12933.
    PubMed    


  425. OBA T, Ono M, Iesato A, Hanamura T, et al
    Chylous leakage after axillary lymph node dissection in a patient with breast cancer.
    Breast J. 2017 Oct 24. doi: 10.1111/tbj.12934.
    PubMed    


  426. KHOURY A, Parihar V, O'steen L, Cherabuddi K, et al
    Pertuzumab and trastuzumab infusion related cytokine release syndrome in a chemotherapy naive patient with metastatic breast cancer.
    Breast J. 2017 Oct 13. doi: 10.1111/tbj.12943.
    PubMed     Abstract available


    September 2017
  427. BIGNON L, Fricker JP, Nogues C, Mouret-Fourme E, et al
    Efficacy of anthracycline/taxane-based neo-adjuvant chemotherapy on triple-negative breast cancer in BRCA1/BRCA2 mutation carriers.
    Breast J. 2017 Sep 19. doi: 10.1111/tbj.12887.
    PubMed     Abstract available


  428. OTA K, Rivera C, Martin M
    Specimen mammography distorts margin status in patients undergoing breast conserving surgery for early-stage breast cancer.
    Breast J. 2017 Sep 15. doi: 10.1111/tbj.12920.
    PubMed    


  429. TANG HKC, Lee DYH, Thompson I, Ingram JR, et al
    Delayed and localized pemphigus vulgaris after breast cancer radiotherapy.
    Breast J. 2017 Sep 11. doi: 10.1111/tbj.12910.
    PubMed     Abstract available


  430. LEE AY, Joe BN, Price ER
    The Predicament of the Probably Benign Breast MRI: Should We Rely on Intuition?
    Breast J. 2017;23:501-503.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: